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Abstract
Acute high altitude (HA) exposure compromises cognitive function thus posing a significant risk
to personnel safety in a HA environment, particularly when performing tasks that requires
cognitive vigilance. Normal cerebral function, and thus cognitive function, is dependent upon
oxygen supply. At HA there is reduced oxygen availability results in compensatory increases in
cerebrovascular blood flow which may be related to nitric oxide (NO), a primary signaling
molecule that acts to increase blood flow and ensure an optimal neurovascular coupling (NVC).
Upon initial ascent to HA, however, there may be reductions in NO production which may play a
role in acute decrements in cerebrovascular/cognitive function at HA. Dietary nitrate may serve
as a means to replenish NO availability. Increasing NO in this manner could have positive
effects on NVC during increased cognitive demand. Purpose: To investigate the effects of acute
nitrate supplementation on 1) cognitive and 2) cerebrovascular function compared to an inert
placebo at HA. Hypotheses: It was hypothesized that compared to placebo at HA, nitrate
supplementation would 1) increase cognitive function, and 2) increase cerebral blood flow.
Methods: 20 healthy men (23 ± 3 yrs, BMI 24.3 ± 3.0 kg∙m-2) participated in this randomized,
double-blind, crossover design study on two separate days. Following sea level (SL)
cognitive/NVC testing, participants consumed either nitrate (NIT) or a NIT-depleted placebo
(PLA). Participants then underwent 120 minutes of HA (11.5 ± 0.2% O2) and all cognitive/NVC
testing was repeated. NVC was assessed by measuring the change in mean middle cerebral
artery (MCA) and common carotid artery (CCA) blood flow during a cognitive challenge
(incongruent Stroop task) using Doppler ultrasound. Brachial artery flow-mediated dilation
(FMD), salivary nitrite, and exhaled NO (in a subset of participants) were assessed as systemic
proxies of NO-metabolism. A computerized testing battery was used to assess cognitive function

across a variety of cognitive domains including memory, executive function, cognitive
flexibility, sensorimotor, and attention. Results: Salivary nitrite and exhaled NO significantly
increased following supplementation at HA for NIT compared to PLA (p < 0.05). FMD
significantly decreased and MCA and CCA blood flow increased at HA in both conditions (p <
0.05). Measures of NVC were unchanged at HA in both conditions. Memory performance
significantly decreased at HA in both conditions (p < 0.05), while all other domains were
unaffected. Conclusions: NIT significantly increased markers of NO-metabolism at HA
compared to PLA. Cerebrovascular blood flow increased at HA compared to SL in both
conditions at rest. NIT, however, was unable to prevent reductions in FMD or memory at HA
nor was NIT able to augment NVC at HA compared to SL.
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Chapter I: Introduction
Numerous populations are exposed to physiologically taxing high altitude (HA)
environments including mountaineers,1 HA natives,2 aircraft pilots,3 and military personnel.4
Acute HA exposure compromises cognitive function across several areas; specifically, it results
in visual impairment,5 impaired complex reaction time,6 loss of motor skills,7 and decreased
marksmanship.8 Moreover, performance decrements cannot be attenuated with cognitivespecific training prior to ascent. These impairments pose a significant risk to personnel safety in
a HA environment, particularly when performing tasks that requires cognitive vigilance.
Normal cerebral function, a critical determinant of cognitive function9, is dependent upon
oxygen supply.10 At HA, the partial pressure of oxygen (PO2) decreases, leading to reduced
oxygen availability, and hypoxemia10 at the expense of critical organs such as the brain. This
results in a compensatory increase in cerebral blood flow (CBF),10-12 to offset drops in blood
oxygen saturation. A primary signaling molecule that may help regulate blood flow in this
setting is nitric oxide (NO). NO is released from the vascular endothelium and acts to relax
vascular smooth muscle, eliciting vasodilation and increased blood flow.13 In addition to its
central role as a regulator of blood flow,14 NO ensures optimal hyperemic response to neural
activity (neurovascular coupling between central and cerebrovasculature),15 and is necessary for
hypoxia-induced cerebral vasodilation.16 Moreover, NO appears to play an integral role in
adaptation to HA.14 Specifically, NO production is elevated following acclimatization to HA,14
and HA natives have been shown to have drastically greater levels of circulating NO products
compared to lowlanders, which was further associated with increased blood flow.17 These
chronic and acclimatization-based adaptations most likely serve to increase oxygen delivery18
and may be related to the improvement in cognitive function with acclimatization.19,20 Some
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populations, such as military fighting units or rescue teams, are often rapidly deployed to HA4
permitting little or no time to properly acclimatize to HA-hypoxia and increase NO production.
This is important since upon initial ascent there may be reductions in exhaled NO,21 indicative of
decreased NO production. This reduction in bioactive NO may play a role in acute decrements
in cerebrovascular/cognitive function at HA. Finding a method to increase NO upon initial
ascent to HA might present a means to positively augment blood flow, neurovascular coupling,
and ultimately attenuate decreases in cognitive performance that occur with sudden acute
exposure.
NO can be synthesized endogenously by NO synthases (NOS),22 or from dietary nitrate,23
a natural ingredient of beetroots, vegetables, and leafy greens.24 Nitrate is subsequently reduced
to circulating nitrite through reactions occurring in the saliva and stomach.25,26 Increasing
circulating plasma nitrite has been shown to increase NO formation27 and peripheral vascular
blood flow27,28 in humans. Furthermore, bioactive levels of plasma nitrite can be attained
through increased intake of dietary nitrate.29 The NOS pathway requires the presence of oxygen,
however the conversion of dietary nitrite to NO takes place preferentially in hypoxic
conditions,29 making nitrate supplementation of particular interest to populations exposed to
hypoxia. Acute dietary nitrate supplementation increases arterial/muscle oxygenation during
high simulated altitude (5,000m).23 Thus, it has been proposed that increased nitrite
concentration via dietary nitrate consumption could enhance NO production during neuronal
activity, augmenting cerebral oxygenation and subsequent neurovascular coupling during
increased cognitive demand.30 In fact, increased dietary nitrate intake increases regional cerebral
perfusion in areas involved in executive functioning (the ability to perform complex, goaloriented tasks)31 in older adults.25 To date, no research has directly investigated the effects of
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nitrate supplementation on cerebral perfusion and cognitive function in hypoxic conditions
observed at HA. Thus, an acute nitrate supplement may be able to attenuate cognitive
decrements following rapid ascent to HA in lieu of proper acclimatization and could be of value
to personnel in HA hypoxic conditions.

The specific aims of the proposed study are as follows:
Aim 1: To investigate the effects of acute nitrate supplementation on cognitive function
compared to an inert placebo at HA.
Hypothesis 1: It is hypothesized that compared to placebo, cognitive function will increase
following acute nitrate supplementation.
Aim 2: To investigate the effects of acute nitrate supplementation on central and
cerebrovascular function compared to an inert placebo at HA.
Hypothesis 2: It is hypothesized that compared to placebo, central and cerebral blood flow
(CBF) will increase following nitrate supplementation.

3

Chapter II: Review of Literature
Exposure to high altitude (HA) is associated with a myriad of environmental and
physiological challenges that can impair physical and cognitive performance and function. This
ultimately compromises the health and safety of personnel exposed to HA without proper
acclimatization. This review will focus on the effects of HA on oxygen kinetics, cognitive
function, cerebrovascular and central hemodynamics, acclimatization to HA, and the role of
nitric oxide in adaptation to HA.
High altitude effects on oxygen diffusion.
Barometric pressure decreases exponentially with increasing altitude, resulting in a
decreased partial pressure of oxygen (PO2) known as hypoxia.10,32 PO2 at a given altitude is
calculated as (PB – 47 mmHg) x 0.2093, where PB is barometric pressure, 47 mmHg is the water
vapor pressure at 37oC, and 0.2093 is the fractional concentration of O2 in the air (which is
unchanged with altitude).33 This equation clearly details the relationship between a decrease in
barometric pressure and the resulting drop in PO2. This altered PO2 has severe effects on the
human body because of altered O2 cascade gradients. The movement of O2 from the alveoli to
the pulmonary capillaries and circulation occurs via passive diffusion32 where the rate of
diffusion is directly proportional to tissue cross sectional area, partial pressure gradient, and gas
solubility.34 At HA a decrease in PO2 leads to a decreased diffusion rate into the pulmonary
vasculature, this results in greater time for hemoglobin (Hb) to become fully saturated.34 This
can result in diffusion limitation at HA, where the rate of diffusion has slowed to the point that
red blood cells and Hb cannot fully saturate as they pass through the pulmonary capillaries.34
Ultimately, the reduced diffusion gradient results in hypoxemia (decreased arterial O2
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saturation), which reduces O2 delivery to tissues and impairs cognitive function and disrupts
cerebrovascular hemodynamics.32
High altitude effects on cognitive function.
Cognitive domains
Cognitive function is generally divided into 7 domains including: attention/concentration,
language, visuospatial skills, psychomotor skills, executive functions, memory and orientation.35
Executive function is an expansive term describing the high-level interrelated cognitive abilities,
dependent on lower-level functions, which are necessary to complete goal-directed behavior.36,37
There is some debate as to the specific components that comprise executive function, but
information processing, attentional control, cognitive flexibility, and working memory have all
been acknowledged as playing a role.35-37 Description of the cognitive domains and tests that
have been used to target them are displayed in Table 1.
Acute effects of high altitude on Cognitive domains
Ascent to HA results in severe impairments in cognitive function38 with more pronounced
effects occurring at more extreme hypoxia.39 Of note, decrements occur independent of acute
mountain sickness32 and can occur within 30 min of exposure.40 Decrements often develop in
memory, motor skills, language, and executive function32 at altitudes greater than 2000-4500 m,5
although some decrements have been documented to occur as low as 1500 m.41 For a brief
summary table of HA effects on divisions of cognition see Table 1. The threshold to observe
memory dysfunction is posited to be approximately 3,500 m.32 There are, however, marked
decreases in spatial memory in both rat models42 and humans43 above 5000 m. Short-term
memory decreases between 3,658 m and 4,600 m in both simulated43,44 and expedition based45,46
5

designs. Typically, memory assessment at HA has used number recitation, digit span, and digit
symbol tests.32
Psychomotor impairment at HA often manifests as decreased motor speed and precision
during complex tasks and decreases with hypoxia.47-50 These decrements in motor skill are
believed to be indirect results from HA hypoxia and are not responsible for changes in reaction
time (RT) with HA.32 RT is comprised of simple (timed response to single unvarying stimuli)
and complex (timed response to multiple stimuli and respective responses) and is a measure of
higher cognitive function.6 There appears to be an inverse relationship between increasing
altitude and RT performance6,51-54 when above a threshold of 4000 m.6 Furthermore, complex
RT appears to be more affected than simple RT, as 2-choice RT does not change with ascent to
8,848 m.49 HA exposure has been linked with impaired cognitive flexibility (as assessed using
the Stroop color test) months after an ascent in world class mountain climbers.
Hyperventilation-induced brain hypoxia (hyperventilation as a means to induce cerebral
vasoconstriction) has also resulted in impaired cognitive flexibility at an arterial O2 saturation of
90%, roughly equivalent to 2,500 m.55
Numerous experimental factors can impact cognitive function at HA such as simulated
HA vs. hypobaric HA, rate of ascent, previous cognition-based training, and difficulty of the
cognitive task. Expedition or transit based ascent to hypobaric hypoxic HA differs from
hypobaric and normobaric simulated HA.32 Studies using expedition-based ascent to HA have a
large number of external environmental factors that may affect cognitive performance; including
fatigue, dehydration, environmental temperature, rate of ascent, and sleep quality.32 Poor sleep
quality at HA has been shown to greatly affect the cognitive decline at altitude56 and rate of
ascent can alter neuropsychological performance at HA, as slower ascent may permit more
6

acclimatization compared to rapid ascents.57 The brain is characterized by neural plasticity and
the ability to improve cognitive functioning through training.58,59 Populations that perform in
significant operational work (such as military personnel) require greater cognitive skills than
other workers, which may lead to better cognitive performance compared to their lesser
developed counterparts.60 Importantly, rather than attenuate decreases in cognitive function at
HA, cognitive-training prior to HA ascent results in more substantial decrements in performance
compared to untrained personnel.60 Moreover, task difficulty plays a large role in the detection
of hypoxia-induced decrements, such that tasks that require higher memory capacity45 or greater
complexity38,50,54 are more affected by hypoxia than simpler tasks. Tasks that document
response time are more useful for highlighting differences in cognitive processing speeds than
non-timed tasks since performance slows at HA, a strategy that may aim to minimize mistakes.5
This suggests that detecting changes in cognition would be most sensitive using complex timelimited tasks following a rapid ascent to an altitude greater than 4000 m.
Neurovascular coupling
Brain metabolism accounts for 20% of the body’s energy and nutrients.61 Proper brain
function is dependent on continuous, adequate perfusion and oxygen delivery provided by the
cerebrovasculature.10,39,61 Blood flow and neural activity are strongly linked such that
insufficient glucose and oxygen delivery to a region of the brain can result in glial cell injury or
death.15 Functional hyperemia is a compensatory increase in blood flow to brain regions where
neurons are active, ensuring adequate blood flow to support neural activity.15 As brain activity
increases, blood flow must increase to meet neural metabolic demands.62 Therefore, optimal
coupling must be established between the brain and blood perfusion, a process known as
neurovascular coupling (NVC).15 The ability of the vasculature to respond to stimuli,
7

appropriately vasodilate and increase blood flow is dependent on endothelial function. In this
manner, cognitive function is linked to the cerebrovascular endothelial function in order to
support neural activity.
The cerebrovascular endothelium, neurons and non-neuronal cells combine to form a
functional unit that is responsible for regulating hemodynamic NVC in addition to other
interactions.63 Since neural activity is dependent on blood flow matching neural metabolic
demand, deleterious changes in vascular and endothelial function can impact NVC and thereby
impair neural and cognitive function. Endothelial dysfunction has been associated with
cognitive impairments,64 with one study reporting worse flow-mediated dilation in participants
with multiple-domain cognitive impairment.65 Vascular cognitive impairment (VCI), is an
umbrella term that has been proposed to represent the spectrum of cognitive decrements
associated with vascular dysfunction and disease (ranging from mild cognitive impairment to
dementia)66 that profoundly affects NVC through changes in blood flow to neurons.63
Hypertension, a risk factor of VCI that contributes to endothelial dysfunction, is
characterized by accelerated atherosclerotic development and decreased endothelium-dependent
vasodilation,67 which may be manifested in the peripheral and cerebral vasculature. Indeed,
hypertension and its sequela are associated with dementia,68 mild cognitive impairments and
disorders,69 and impaired executive function.70 Cerebrovascular disease is linked to greater
declines in cerebral blood flow (CBF)71-73 and decreased hyperemic reserve capacity,74
suggesting impaired NVC as the vasculature cannot adapt to the increased demands, resulting in
blunted blood flow responses to neural activity.75 This has been shown in older adults who have
been reported to have depressed NVC compared to younger adults.76-78 Contrastingly, beneficial
changes in vascular function have been reported to attenuate and even reverse this process.
8

Specifically, as vascular function improves, as reported with exercise training, measures of
cognitive function (executive function and working memory) similarly improve79,80 at least in
part through beneficial adaptations in the cerebrovasculature. In this manner, cognitive
performance and neural activity are dependent on the vasculature (through NVC) for proper
function and any dysfunction or abnormalities in the cerebrovasculature, resulting from
environmental challenges or perturbations, may compromise the integrity of brain function.61
Effects of high altitude on cerebrovascular hemodynamics
Cerebral blood flow
Cerebral hemodynamic responses to HA-induced hypoxia result from two competing
compensatory reactions. The development of hypoxemia at HA results in a compensatory
increase in CBF10,39,81,82 via increased flow velocity,57 and relaxation of the cerebral arterioles
and/or release of vasodilator substances.39,81 Perfusion-based increases in oxygen delivery are
necessary because there is no capillary recruitment in the cerebrovasculature, meaning increased
brain metabolism is dependent on enhancing the diffusion gradient.39 Ventilation increases with
increasing altitude in order to positively augment arterial saturation of oxygen.83,84 However,
although arterial PO2 increases, there is a concomitant decrease in arterial PCO2, which
potentiates cerebral vasoconstriction, acting to decrease CBF.85,86 In this manner, the given CBF
response to HA-hypoxia is a result of the balance between a compensatory vasodilation response,
seeking to increase oxygen delivery, and vasoconstriction responding to decreased arterial
PCO2.39,87 These competing responses can result in unaltered,86 increased10,39,81 or decreased88
CBF depending on external factors such as the magnitude of hypoxia, as well as cerebrovascular
and ventilatory oxygen and carbon dioxide sensitivity.87 External stimuli such as exercise or
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cognitive tasks may be required to create perturbation sufficient to quantify changes in CBF at
HA.
Cerebral perfusion is largely dependent on changes in vessel diameter and blood flow
velocity. It has generally been shown that CBF velocity (CBFv) increases with HAhypoxia,57,81,89 although this finding is not universal.10,90 Recent data has suggested that cerebral
vessels vasodilate in response to HA.10 Wilson et al (2011) documented changes in the middle
cerebral artery (MCA) during an Everest expedition to 7,930 m in addition to a simulated HA
condition using magnetic resonance imaging to quantify changes in the MCA.10 Their results
demonstrated no change in CBFv during the expedition, while diameter increased drastically
above 6,400 m. In the simulated HA study, MCA diameter similarly increased following 180
min at 4,400 m, although CBFv also increased compared to baseline.10 This suggests that
vasodilation plays a larger role in the response to HA-hypoxia than originally believed, although
these changes in diameter were principally seen at extreme HA and after three hours of
simulated-HA.10 Moreover, the changes in MCA diameter were reversed under supplemental
oxygen use, suggesting that increased CBF is a direct hypoxic effect.10 More recently, however,
CBFv was shown to increase during a 6-day HA sojourn and remain significantly elevated 6-hr
post descent.89 Which may suggest that changes in cerebral hemodynamics rely mechanisms
other than vasodilation since CBF remained elevated after returning to normoxic conditions.89
CBFv measured via transcranial Doppler (TCD) has been widely used to document CBFv
across rest, exercise, and cognitive perturbations in normal and pathological populations,91 as
well as in different environmental conditions, including HA.10,16,57 This method assumes that
diameter of cerebral vessels are relatively unchanged during different physiological stimuli, and
thereby indirectly estimates blood flow.91 It has been recently suggested that cerebral
10

vasodilation occurs frequently at HA to increase CBF,10 which would not be quantifiable using
TCD. Importantly, there are additional noninvasive methods to indirectly assess changes in
cerebrovascular tone and altered CBF. Doppler ultrasound can be used to document changes in
carotid hemodynamics, which feed into the MCA and other cerebral arteries and provide
information on blood flow to the brain.92-96
High altitude acclimatization
Upon ascent to HA, there are decrements in both cognitive and physical function.97 Fortunately,
human physiology undergoes a series of adaptations and adjustments to compensate for the
hypoxic environment.97 Adaptations to prolonged hypoxic exposure (days to weeks) are
beneficial and paramount in the ability to survive at HA, although they do not return bodily
functions to sea level performance.33 Importantly, these adaptations take time to develop before
performance is positively affected. The rate of adaptation varies based on rate of ascent, peak
altitude, and individual physiology.98 Adaptations can occur within the first days to weeks or
can occur from chronic exposure (such as the native populations of the Tibetan high plains).
Ultimately, acclimatization-based adaptations can serve as a model to elucidate how best to
design interventions intended to maintain performance during acute exposure to HA without
proper acclimatization.
Oxygen transport
Initial key adaptations to HA-hypoxia pertain to augmenting oxygen saturation.
Hyperventilation, achieved through deeper and more frequent breathing, increases alveolar
ventilation by as much as 5-fold and is often referenced as the most important HA adaptation.33,99
This occurs through the hypoxic ventilatory response and leads to greater blood oxygen
11

saturation, and a concomitant decrease in CO2 in the blood.97 As discussed previously, the
hyperventilatory response to HA may affect cerebrovascular responses, as hypocapnic conditions
can precipitate cerebral vascoconstriction.85,86 The decrease in CO2 causes a shift in acid-base
balance, leading to respiratory alkalosis, a process by which excess CO2 exhalation decreases
hydrogen ion concentration in the blood, resulting in an increase in pH. Within a week the body
compensates by lowering the bicarbonate concentration in the blood via urinary excretion, acting
to balance pH while maintaining elevated ventilation and oxygen saturation.
Hematological adaptions occur in parallel to respiratory adaptations to maximize oxygen
transport.100 There is an increase in red blood cells (RBC), the primary oxygen transporter in the
body, which initially results from reduction in plasma volume, but later from erythropoiesis (the
production of new RBCs). Erythropoiesis can begin as early as 24-48 hours after ascent, evident
by elevated plasma erythropoietin, the glycoprotein responsible for stimulating RBC
production.101 Importantly, when increased RBC production is coupled with dehydrationinduced decreases in plasma volume, a frequent occurrence at HA,102 there is a marked increase
in RBC concentration97 and blood viscosity. These changes, when combined with small shifts in
the oxygen-dissociation curve, facilitate greater oxygen unloading and delivery to tissues, which
improve function at HA although do not permit a full return to sea level performance.
Oxygen delivery
The effects of HA acclimatization on oxygen delivery and cardiovascular adaptations remain
somewhat less clear. There are conflicting results regarding the cardiac acclimatization
response, with some findings suggest decreased cardiac output100 and others finding a return to
baseline103 or no change104 following prolonged exposure. Ultimately, heart rate remains
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elevated following acclimatization in order to compensate for the decreased plasma volume and
ventricular filling time.103
Increased oxygen transport, elicited from the aforementioned adaptations would be
expected to favor brain-tissue oxygenation and potentially attenuate decrements in cognitive
performance. Indeed, a study by Pagani et al reported that acclimatized mountaineers out
performed non-acclimatized participants at 5,350 m in cognitive function.20 Notably, these
results are limited by the cross-sectional design, but none the less suggest that acclimatization
may improve cognitive function. Another study showed no difference in saccadic eye
movement, a marker for impaired cerebral performance, following prolonged stay at very high
altitudes.1 Consistent with these findings, HA natives do not appear to have severe decrements
in cognitive function. Cognitive function in adolescent HA natives has been reported to be
similar to their lowland counterparts, indicating no evidence of compromised function while
being tested at their native altitudes.2 Moreover, event-related potentials in the brain electrical
activity were similar between HA and lowland natives during cognitive testing.2 Despite
increased oxygen carrying capacity of the blood following acclimatization, cognitive
performance still depends on NVC, and the ability of the vasculature to respond and increase
blood flow to the active areas of the brain. Therefore, any increase in cognitive function with
acclimatization must depend on the matching of blood flow by the vascular system to neural
activity.
Role of nitric oxide in vascular adaptations
There are rather limited data on vascular responses to HA acclimatization, as much of the
literature focuses on cardiorespiratory adaptations. However, some of the most insightful

13

research into vascular adaptations to HA has been derived from studying native populations to
HA, specifically from Tibet. Tibetan HA natives have been shown to have less saturated Hb,105
and lower concentrations of Hb and erythropoietin106 compared to their Andean HA
counterparts. These adaptations, or lack thereof, result in lower arterial oxygenation content,
which would suggest their HA performance would be impaired. In fact, Tibetan’s cardiovascular
adaptations may target the oxygen delivery through the vascular system and blood flow’s
dependence on vasodilation, rather than oxygen transport.107
Tibetan HA natives have been reported to have extremely high levels of exhaled nitric
oxide (NO),108 a potent vasodilator and modulator of blood flow produced by the vasculature,13
compared to lowlanders and other HA natives. This up-regulation of NO production and
bioavailability likely plays a large role in increased blood flow for oxygen delivery. Indeed,
rather than vasoconstrict pulmonary vessels, Tibetan HA natives display vasodilation of the
pulmonary vasculature, normal blood flow, and essentially no pulmonary hypertension.109,110
This is in contrast to the typical lowlander response to HA which includes a down-regulation of
NO synthesis,21,111 and the development of severe HA performance limitations. This enhanced
NO bioavailability is related to increased systemic blood flow (indicated by forearm blood
flow),17 lung blood flow,110 CBF during exercise,95 and greater hyperemic responses to
temporary occlusion.112 In this manner, higher blood flow may offset the low arterial oxygen
content observed in this HA population,113 and the key adaptation may revolve around the upregulation/ bioavailability of NO.
The decrease in NO bioavailability experienced by lowlanders during acute HA exposure
is thought to be caused by reduced enzymatic production, and reaction oxygen specie (ROS)
interference.114,115 Enzymatic production depends on oxygen availability and thereby decreases
14

in hypoxia, while the production of ROS inactivates NO.14,115 Importantly, levels of bioactive
NO increase as acclimatization proceeds and relative function improves in lowlanders.14 Levett
et al demonstrated that plasma biomarkers of NO production (nitrate/nitrite) are increased
following acclimatization, with increases evident as low as 1,300 m and with the largest gains
noted following the greatest rate of ascent.14 This suggests that NO-based adaptations to HA are
not unique to Tibetan HA natives,14 although their adaptions are to a far greater extent compared
the lowlander acclimatization response. Moreover, it offers the possibility that increasing NO
upon initial ascent to altitude may attenuate the initial, large decrements in performance prior to
hematological adaptations that occur with acclimatization.
Nitric oxide and the nitrate-nitrite-nitric oxide pathway
Nitric oxide can be synthesized endogenously by NO synthases (NOS),22 or from dietary
nitrates via the nitrate-nitrite-nitric oxide (n-n-NO) pathway.23 It is an autocrine and paracrine
signaling molecule29 that plays a role in regulation of endothelial function.114 Once created, NO
diffuses into the vascular smooth muscle, activating guanyl cyclase and in turn, causing
relaxation of the vascular smooth muscle (vasodilation).13,114 NO has been implicated in the
systemic blood flow response to mental stress (induced via cognitive challenges),116 as well as
blood flow responses to HA,16 hypoxic vasodilation of cerebral vessels,16,117 and proper
acclimatization/adaptation to HA,14 as discussed previously. Importantly, research has suggested
that NO plays a role in optimizing NVC.
The appropriate hyperemic vascular response to neural activity, discussed previously, is
believed to occur via feed-forward mechanisms.15 Specifically, neuron signals potentiate the
release of vasoactive agents (Figure 1). With increased neural activity there is increased synaptic
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release of glutamate, which binds to neuron receptors, leading to a calcium influx, activation of
neuronal NOS, and increased NO production.15 Glutamate can also bind to active astrocytes,
resulting in increased arachadonic acid formation which can increase both vasodilatory and
vasoconstrictor messenger production.15 Importantly, NO concomitantly inhibits vasoconstrictor
substances that may be derived from arachadonic acid118 in addition to its vasodilatory functions,
in attempt to optimize the vascular hyperemic response. Research has demonstrated that NO has
an integral role in establishing NVC. If neuronal NOS is inhibited, thereby decreasing NO
bioavailability in the cerebrovasculature, functional hyperemia is decreased by 37-60% in the
somatosensory cortex,119,120 and 50-90% in the cerebellum.121-124 NOS activity is dependent on
oxygen, and NO synthesis is thus limited by oxygen availability.15 Importantly, NOS activity
and creation of NO depends on reacting L-arginine with oxygen, whereas the n-n-NO pathway
does not require oxygen for reaction and, in fact, gradually increases activation as oxygen
tension decreases.29 In this manner, the n-n-NO pathway serves as a NOS-independent NO
formation pathway that can increase NO production as NOS reactions are attenuated.29 This may
be of greater importance when operating in hypoxic conditions (such as HA), when NOSdependent formation may be impaired.
Once NO has been formed, its lifetime and diffusion capabilities depend on scavenging
radicals, that can quickly react with circulating NO.29 NO oxidation to nitrate (NO3-) or nitrite
(NO2-) may present a more stable form that can circulate and be converted back to NO under
hypoxic conditions.29 This suggests that nitrite may be a primary modulator of hypoxic
vasodilation and blood flow at HA. Research has demonstrated that increased plasma nitrite is
associated with greater forearm blood flow,125 peripheral blood flow,27,28 and NO formation.27
Nitrate/nitrite must be reduced to the bioactive from of NO and research suggests that Hb may
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act as an allosterically-regulated nitrite reductase, generating NO and contributing to hypoxic
signaling and vasodilation.27,126,127 Moreover, it appears that maximal nitrite reduction rates
occur when Hb is 40-60% saturated with oxygen,127 meaning that if plasma nitrite is available in
such conditions there will be increased NO formation and vasodilation.
Nitrates can be readily consumed through diet, as they are natural ingredients in of
beetroots, vegetables, and leafy greens,24 and can increase bioactive levels of nitrite adequate for
increased NO formation.29 Ingested nitrate is quickly absorbed from the upper gastrointestinal
tract29 and is transported to the salivary glands where it is reduced to nitrite via anaerobic
bacteria before re-entering the gut.128 Some of the nitrite is converted to nitrous acid, which
dissociates to form NO,129,130 while some nitrite is absorbed through the intestines and enters
circulation.26 Indeed, following a dietary nitrate bolus, plasma, salivary and urine levels of
nitrite increase, indicating greater storage pools for NO formation.131 Increased nitrite could aid
in the vascular adjustments attempting to increase oxygen delivery during acute exposure to a
hypoxic environment through increased NO formation.
High dietary nitrate intake in older adults has been shown to increase regional cerebral
perfusion to the frontal cortex compared to a low dietary nitrate group.25 Moreover, nitrate
supplementation has been shown to result in shorter hyperemic lag times to visual stimulation,
indicative of improved NVC in healthy males.30 At both low and HA, administration of a
sublingual NO donor resulted in cerebral vasodilation (evident through decreased CBFv) in two
different HA native populations.16 Dietary nitrate consumed prior to a rapid ascent to 5000 m
resulted in significantly higher arterial/muscle oxygenation during submaximal and maximal
exercise compared to placebo.23 This study concurrently noted no change cerebral oxygenation
and estimated flow which may be a direct result of the exercise stimulus. Specifically, exercise
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at HA causes a marked increase in ventilation, that concomitantly decreases the partial pressure
of CO2, causing vasoconstriction of cerebral vessels. Therefore, the insignificant changes in
cerebral perfusion may have resulted from an intense, compensatory reaction to vasoconstrict
vessels. The effect of nitrate supplementation on cognitive responses to acute HA exposure has
yet to be elucidated.
Proposed study
Dietary nitrate supplementation may serve as a means to mimic Tibetan HA natives’
adaptations to acute HA-hypoxia prior to compensatory acclimatization. Tibetan natives
accommodate large changes in blood flow and oxygen delivery through increased NO
bioavailability, rather than up-regulation of oxygen transport.108 Increased nitrate availability
during HA exposure may potentially reduce hypoxic performance decrements. High
concentration of nitrates would result in greater ability of the n-n-NO pathway to augment NO
formation, especially in the face of hypoxic deactivation of the NOS pathway.29 This would in
turn act to increase vasodilation, increasing blood flow16,117 and oxygen delivery, as well as
optimizing NVC by facilitating more rapid hyperemic responses to neural activity.30 In this
manner, nitrate supplementation could act to improve or attenuate decrements in cognitive
performance following rapid ascent to HA. Therefore, the purpose of this study is to document
the effects of acute nitrate supplementation compared to a placebo on 1) cognitive function at
HA and 2) cerebrovascular function at HA. It is hypothesized that cognitive function will
improve and that cerebrovascular blood flow will increase compared to the placebo at HA.
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Chapter III: Methodology
Participants
20 Recreationally active men, age 18-30 yrs, were recruited from the local University
community for this randomized, double-blind, crossover-design study. Exclusion criteria
included self-reported (health history questionnaire) smoking, hypertension, diabetes mellitus,
hyperlipidemia, pulmonary disease, renal disease, neurological disease, or peripheral artery
disease. All participants provided written informed consent prior to study initiation. Testing was
conducted at the same time of day in a temperature-controlled laboratory. Participants were
instructed to fast for ≥ 3 hours and avoid vigorous exercise and avoid consuming caffeine and
alcohol the day of testing. Additionally, participants were given a list of high-nitrate foods to
avoid for the 2 days prior to experimental testing. Height and weight was assessed via wallmounted ruler and electronic scale, respectively, and body composition was estimated via air
displacement plethysmography (BodPod; COSMED, Concord, CA).
Design
Participants rested in the supine position for 10 minutes upon arrival before baseline
(normoxic) vascular and cognitive measures were assessed. Participants consumed either a) a
0.45 g nitrate bolus (Beet It Sports Shot; NIT) or b) an inert placebo (PLA) prior to exposure to
HA in a randomized order. This single dose of nitrate has been previously reported to
significantly increase plasma nitrite concentration at HA (2,500 m).26 Participants remained at
HA for 105 minutes before undergoing HA vascular and cognitive testing (Figure 1). This
timeline was chosen so that cognitive testing would occur at approximately 2 hrs post-nitrate
ingestion since previous literature suggests peak plasma nitrite levels occur between 2-3 hrs post19

ingestion (and remain elevated for approximately 2 additional hours).25,132 HA testing was
conducted in a normobaric hypoxic chamber (Hypoxico Systems) at simulated altitude
conditions approximately equivalent to 4,500 m (achieved by lowering the fractional
concentration of inspired oxygen (FiO2) to approximately 11.5 ± 0.2% O2). Oxygen
concentration was measured using an oxygen monitor (PureAire Monitoring Systems Inc., Lake
Zurich, IL) secured inside the hypoxic chamber. This altitude was chosen based on previous
research that established 4000-5000 m as the critical altitude for changes in cognitive function.133
Vascular Measures
Arterial Hemoglobin Concentration and Saturation
Arterial oxygen saturation was assessed using a reflectance pulse oximeter placed
forehead (Nonin Medical, Plymouth, MN) at baseline, and during vascular testing. The forehead
reflectance sensor was secured using adhesive and a flexible head band to the forehead just
above the brow. Hemoglobin concentration was assessed at baseline via finger-stick blood
sample and microcuvette (The Hemocue Hemoglobin System, Hb201+; Angelholm, Sweden).
End-tidal CO2
End-tidal CO2 (EtCO2) was measured (Nellcor OxiMax, Covidien, Mansfield, MA) at sea
level and HA baseline with sampling lines secured directly under the nostrils. Participants rested
for 10 minutes prior to assessment to ensure resting values. Data was collected over a 5-minute
period with triplicate measures taken during minutes 2-4 and averaged.
Nitrite and Exhaled Nitric Oxide
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Salivary nitrite was qualitatively assessed using salivary test strips (Berkeley Test,
Berkeley, CA). A salivary absorbent pad was placed under the tongue for 3-5 s and then pressed
against a reagent strip. The resulting color was compared to a colored scale to qualitatively
assess nitrite availability. Exhaled NO was measured in a subset of participants using a NIOX
MINO (Aerocrine AB Solna, Sweden). This method has been described in detail previously.134
Briefly, participants were instructed to empty their lungs and fully inhale through the NIOX
MINO mouthpiece before beginning a paced exhalation (approximately 5 seconds). The
participants exhalation was guided by a visual cue program that provided immediate feedback
allowing the participant to adjust the exhalation force to the target level (i.e. too forceful an
exhalation would push the needle farther right on the computerized display dial). Nitrite/NO
availability was assessed at sea level and approximately 2 hours after nitrate ingestion/HA
exposure. This timeline was chosen based on previous findings that report nitrite/NO availability
to peak approximately 2 hours post-ingestion.25,132
Brachial Blood Pressure
Systolic blood pressure (SBP) and diastolic brachial blood pressure (DBP) were
measured prior to each set of vascular measures (baseline, HA) using a validated, automated
oscillometric cuff (EW3109, Panasonic Electric Works, Secaucus NJ). Pressures were taken in
duplicate and averaged. If values were different by more than 5 mmHg a third measure was
obtained and the average of the 2 closest measures were used for subsequent analyses.
Doppler Ultrasonography
Images of the left common carotid artery (CCA) and brachial artery (BA) were obtained
using Doppler ultrasound (ProSound α7, Aloka, Tokyo, Japan) and 7.5-10.0 mHz linear-array
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probe. The CCA was imaged distal to the carotid bulb. CCA and BA intima-media thickness
(IMT) were assessed using a longitudinal view with both near wall and far wall lumen-IMT
boundaries visible. Wall thickness was measured across a 5 mm region of interest via semiautomated digital calipers during systole and diastole (indicated by the R-wave and end of the Twave from simultaneous ECG gating). The distance from the lumen-intima interface to the
media-adventitia interface was measured as the IMT. IMT was measured across the cardiac
cycle and at each time point given findings that 1) IMT may change during the cardiac cycle; and
2) IMT may be altered with changes in vascular tone.135 Systolic and diastolic diameters were
measured from inside the near-wall IMT to far-wall IMT. Mean blood velocities (Vm) were
measured using Doppler-ultrasound and calculated as: Vm = ∫ V(t) dt/FT, where ∫ V(t) dt is the
velocity-time integral of the velocity waveform and FT is flow time. Flow and shear rate were
calculated as π x (1/3 systolic radius + 2/3 diastolic radius)2 x Vm x 60 and 4 x (Vm/systolic
diameter), respectively. Pulsatility index (PI) was calculated with a semi-automated flow tracing
software using the following equation: (Vs-Vd)/mean V, where Vs is the peak systolic velocity, Vd
diastolic velocity and mean V the mean velocity.
Wave intensity analysis (WIA) combined with eTracking was used to derive forward and
reflected wave intensity as measures related to pulsatile cerebrovascular burden and arterial
stiffness in the CCA. WIA was performed immediately after carotid applanation tonometry on
the left CCA. The distance from the near wall to far wall lumen-intima interface was
continuously traced using eTracking software, creating a distension waveform almost identical to
pressure waveforms.136,137 WIA distension waveforms were calibrated against carotid systolic
and diastolic pressures obtained via applanation tonometry described below. Flow waveforms
were measured using range gated color Doppler signals averaged along the Doppler beam. An
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insonation angle < 60° was maintained for all measures and sample volume was manually
adjusted to encompass the entire vessel. At least 8 carotid waveforms were averaged to gain a
representative average waveform. Wave intensity was calculated using time derivatives of blood
pressure (P) and velocity (U), where wave intensity = (dP/dt x dU/dt); the area under the dP/dt x
dU/dt curve represents the energy transfer of the wave.138 W1 represents a forward compression
wave produced by the left ventricle that can travel into the cerebral circulation via the CCA
which acts to accelerate flow and increase pressure. The negative area (NA) occurring
immediately after W1 is a backward travelling compression wave due to reflected waves from the
periphery (cerebral circulation) that decelerate flow but increase pressure. Measures of CCA
wave reflection (i.e. NA) have been reported to be related to altered cerebrovascular tone, as
changes in cerebral resistance would affect the magnitude and timing of pressure waves being
reflected from the brain as they travel down the CCA.92,93 The time interval between the R-wave
on the ECG and W1 is analogous to the pre-ejection period136 and has been used as a proxy of
peripheral sympathetic activation.139
Arterial stiffness measures include beta stiffness index (β), and Peterson's pressure-strain
elastic modulus (Ep) and were calculated as:
β = ln(PMax/PMin)/[(DMax - DMin)/DMin]
Ep = (PMax - PMin)/[(DMax - DMin)/ DMin]
where P and D correspond to pressure and diameter respectively, and Max and Min refer to
maximum (systolic) and minimum (diastolic) values during the cardiac cycle.
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Flow mediated dilation
BA flow mediated dilation (FMD) was assessed in the non-dominant arm during two
separate protocols; cuff occlusion and mental stress. BA FMD has been previously reported to
be a largely endothelial and nitric oxide-dependent process,140 with impaired vasodilation
occurring from impaired/inhibited nitric oxide synthesis (as occurs in hypoxic conditions or drug
blockade). The BA was imaged using ultrasonography described above with diameter and
velocities measured as previously described. For the cuff-occlusion method, blood flow was
occluded using a rapid inflator cuff (Hokanson, Bellevue, WA,) placed just below the olecranon
process, inflated to suprasystolic pressure (>200 mmHg) for 5-minutes. Blood flow velocity was
assessed for the first 30 seconds following cuff deflation to obtain peak shear rates. BA diameter
was assessed using semi-continuous image capturing synced to the QRS complex from
simultaneous ECG gating until two minutes post cuff deflation. Additionally, FMD was also
measured during the Stroop task (described below) to measure mental stress BA vasodilation,
which has previously been reported as primarily NO-mediated.116 FMD was calculated as peak
percent change from baseline for both methods.
Carotid Blood Pressure Waveform Analysis
Carotid pressure waveforms were obtained from a 10 s epoch and measured in duplicate
using applanation tonometry (SphygmoCor, AtCor Medical, Syndey, Australia) on the left CCA.
Carotid pressure waveforms were calibrated to brachial MAP and DBP. Pulse pressure (PP) was
calculated as SBP minus DBP. Augmentation index was calculated as the difference between
the early- and late systolic peaks of the pressure waveforms to the total PP expressed as a
percentage (P2 − P1/PP × 100) and standardized to a heart rate of 75 beats per min (AIx75).

24

Cerebral Blood Flow
Middle cerebral artery (MCA) blood flow velocity was assessed using a 2-mHz
transcranial Doppler (TCD) ultrasound probe (DWL Doppler Box-X, Compumedics, Germany)
applied to the left temporal window. Mean blood flow velocity (MnV) and pulsatility index
were measured at a depth of 50-65mm, as is commonly reported for MCA measurements.141,142
All repeated measurements within each participant were taken at the same depth and position to
ensure recapture of the same cerebral artery. The envelope of the velocity spectrum and mean
velocity was calculated by a standard algorithm implemented on the instrument with use of a fast
Fourier transform. MCA PI was calculated via an automated waveform tracking function using
the same equation described for CCA PI. Cerebrovascular conductance (CVC) was calculated as
CVC = Vmean/MAP.
Vascular Reactivity to Mental Stress
A computerized, modified incongruent Stroop color-word interference task (E-Prime,
Psychology Software Tools Inc, Sharpsburg PA) was used as a means to manipulate cognitive
load. This task has been used previously in HA cognitive,32 and cardiovascular stress
research.143-145 All participants were familiarized with the Stroop task prior to experimental
testing in order to control for learning effects. The Stroop task was completed in the supine
position with the head tilted slightly back, thereby optimizing the imaging window of the carotid
artery. The viewing display for sea level testing was a specialized wall-mounted 107-cm flat
screen television that extended over the participant. Font was displayed approximately 102-cm
above the participant with 3.0-cm font on a black background. For HA testing, the Stroop task
was projected onto the ceiling of the chamber using a computer-interfaced projector (INFO) that

25

displayed the task approximately 160-cm above the participant with 4.5-cm font. Despite the
task being displayed farther away from the participant at HA, the ratio between viewing distance
(cm) and font size (cm) was comparable to sea level (34:1 sea level, 36:1 HA).
Each trial began with participants presented with a white crosshair in the center of the viewing
window for approximately 3-seconds. A target word was displayed in incongruous colors (e.g.
the word “blue” written in the color red; Figure 2), with four names of response colors presented
similarly (e.g. the word “red” written in the color blue). The task was to use a response clicker to
identify the color that the target word was displayed in as fast as possible. The response colors
(1-4) corresponded to the remote clicker buttons (1-4) which the participant manipulated using
the digits on their dominant side (index finger – pinky finger). This task lasted 4-minutes in
duration, which has been previously been shown to elicit marked changes in HR and BP.145
Participant’s identification accuracy was titrated to 60% in order to produce equivalent
hemodynamic responses across sea level and HA stroop testing. This was achieved via
manipulation of the inter-trial timing intervals (ITI). For every three consecutive trials answered
correctly the ITI was decreased by 300 ms (shortest ITI of 400 ms). Similarly, three consecutive
missed trials would increase the ITI by 300 ms (longest ITI of 5,000 ms). If the participant did
not respond in time, a large “TOO LATE!” prompt was displayed before the next trial was
displayed. Percent correct and mean reaction times (RT) for correct response were recorded for
analysis. This test has been previously used as a mental stressor, and measure of executive
function.
Vascular measures, described above (carotid tonometry, WIA, CBF), were also assessed
during the 4-minute Stroop task. Previous data from this laboratory (unpublished) has revealed
that there are no significant differences between primary outcome measures across three time
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points during the Stroop task. Thus, vascular measures were assessed once during the Stroop
task in the following order; carotid blood pressure, carotid blood flow/WIA, and mental stressmediated brachial vasodilation beginning 30-seconds after task initiation. CBF was averaged
across two measurements during the task. This provides a novel means of performing vascular
measures while concomitantly manipulating cerebrovascular reactivity. Psychological stress
from cognitive tasks causes arteries to dilate. Change in cerebrovascular blood flow measured
during increased brain activity with sensori-motor/cognitive stimulation has been reported to
reflect changes in cerebral metabolism and was used as a measure of neurovascular coupling.146
Additionally, mental stress-mediated dilation of the CCA was used as a measure of CCA
endothelial function.116,147-149 Cerebrovascular reactivity metrics were calculated as percent
change from baseline.
The Student Opinion Scale was administered after each Stroop task to measure
participant motivation for each trial (two subscales: [a] the importance of doing well on the task;
[b] perceived degree of effort/mental taxation put forth to complete the task). Scores for each
subscale can vary from 5-25, with higher scores indicative of full effort/engagement to do well.
Cognitive Measures
Computer-based cognitive assessment
Additional measures of cognitive function were assessed through a computer-based
program (WebNeuro; Brain Resource, San Francisco CA). The cognitive tests have been
described in detail previously,150 brief summaries of the tests are provided below.
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Sensorimotor domains
Simple motor tapping test. Participants were required to tap the space bar on the keyboard with
their dominant index finger as fast as possible for 30 sec. The total number of taps was recorded.
Choice reaction time test. Participants were required to use the left/right arrow keys to respond as
fast as possible to two target circles that were illuminated in pseudorandom sequence over a
series of trials. Trials were administered with a random delay of 2–4 sec between trials. Mean
RT was recorded from the trials.

Memory Domain
Memory recognition/verbal learning task. 20 words were presented for memorization and later
recognition from memory. The list contained 20 concrete words from the English language
(matched for word length and frequency). The list was repeated four times. After each trial, the
participant was instructed to recognize as many words as possible by deciphering between 20
sets of words on the screen. In each set, one word was correct and the other 2 were distracter
words. Approximately 10-minutes after the fourth trial (6 test batteries), a delayed memory
recognition trial was completed. The number of words correctly recognized during the four trials
and memory recognition trial were averaged and used to calculate verbal memory index151
(immediate verbal memory recognition + delayed verbal memory recognition), and verbal
intrusion index (immediate verbal memory intrusions + delayed verbal memory intrusions).

Social Cognition Domain
Emotion perception test. Participants were presented with a succession of faces with diverse
emotional expressions in order to test emotion recognition. The mouse was used to identify the
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emotion that best described the facial expression by clicking on one of 6 emotion words below
the image (happy, sad, fear, disgust, neutral, angry) as quickly as possible. The total number of
correct responses, and reaction time was recorded. Approximately 10 minutes after completion,
the participant was asked to recall the faces they had been presented before. Target faces (from
the previous trial) were presented next to a new face. The participant was instructed to select the
face that they have been presented with before by clicking with the mouse as fast as possible.
The immediate and delayed emotion recognition accuracy scores were summed, similar to
memory task performance, to form the emotion recognition index (out of a perfect score of 200),
and RT’s were averaged for analysis purposes.

Attention Domain
Digit span test. Participants were presented with a series of digits, separated by a one second
intervals. The participant was required to enter the digits in the correct forward order using the
mouse and a number pad displayed on the screen. The number of digits in each sequence
increased from 3 to 7 with the outcome being the maximum number of digits the participant
correctly recalled.
Continuous performance test. To assess sustained attention, a series of letters similar in
appearance (B, C, D, or G) were presented on the screen (200 msec), separated by 2.5 sec
intervals. The participant was instructed to press the space bar as fast as possible if the same
letter appeared twice in a row. There were 125 stimuli presented in total (85 non-target letters,
20 target repeated letters). The number of errors and false positives were recorded.
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Executive Function Domain
Switching of attention test. This is a computerized adaptation of the “Trail Making Test” Part
B152 where the participant was presented with a distribution of 13 numbers (1–13) and 12 letters
(A–L) on the screen. The mouse was used to click on the circles for numbers and letters in and
alternating, ascending sequence (e.g. 1, A, 2, B, 3, C etc.). Each correct number/letter that
selected was connected to the preceding number by a line. This task aims to assess the ability to
switch attention between mental tasks (number versus letter sequence). The time to completion
was recorded.
Verbal interference test. This task is similar to the Stroop described above and is intended to
assess the ability to inhibit automatic and irrelevant responses. A target color word (red, yellow,
green, and blue) was presented one at a time. Below each target word there were four possible
responses displayed in black and in fixed format. The first part of this task required the
participant to identify the name of each word, ignoring the color of the word, as quickly as
possible. The second portion required the participant to name the color of each word as quickly
as possible. The number of correct responses in the minute allotted for each test was recorded.
Maze test. The participant was presented with an 8 x 8 grid of circles on the screen. The goal of
the task was to correctly identify the hidden path through the grid, from the start point (bottom of
the grid) to the end point (top of the grid). Grid navigation was controlled via pressing the arrow
keys (up, down, left, right). An incorrect move was denoted by a red cross at the bottom of the
screen, a green tick signified a correct move. The task aims to quantify how quickly the correct
route is learned and the ability to remember that route. A single maze was presented until it was
completed twice without error. The total maze time was recorded. This task measures aspects of
executive function and memory through requiring the correct path to be repeated without errors.
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Go–no-go test. Participants were instructed to press spacebar as quickly as possible every time
the word “press” was displayed in green (go) and not press spacebar if it was colored red (nogo). Green was repeated frequently and red repeated less frequently. Stimuli were repetitively
presented approximately once per second. This requires inhibition of responses when the target
is colored red, thereby assessing the capacity to suppress automatic responses (known as
inhibition). This task measured errors of commission and omission, rate of target detection, and
response time.

Statistical analyses
Averaging effect size values from previous literature for cerebral blood flow (0.65)81,
reaction time (0.48)60 and memory (0.89)7 at HA suggested an effect size of 0.67. Therefore, for
a power of 0.80 with alpha set as 0.05 for a two-tailed T-test, approximately 20 participants was
determined to be sufficient to observe similar changes in blood flow and cognitive function at
HA.
All data are presented as mean ± standard deviation. Normality of distribution for
variables was assessed qualitatively using histograms and Q-Q plots as well as quantitatively
using the Shapiro-Wilk test. The effect of altitude exposure was tested using paired T-tests
between SL and HA. The effect of NIT was tested using paired T-tests between NIT and PLA at
HA. Significance was set a priori at p < 0.05. Stroop RT’s greater than 2.5 standard deviations
above or below the mean RT were removed as outliers prior to analyses. Reactivity scores
(absolute ∆) were calculated as mental-stress – baseline, for each treatment (PLA, NIT) and
condition (SL, HA).
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Chapter IV: Results
Participants were young men (23 ± 3 yrs) in overall good health (BMI 24.6 ± 2.8 kg∙m-2,
body fat 13.3 ± 6.8%, hematocrit 43 ± 3%, hemoglobin 14.7 ± 1.5 g/dL; Table 3). Twenty-four
participants were recruited for this study: two participants were lost to follow-up and of the 22
remaining, 21 completed the trials. One participant experienced a syncopal episode upon ascent
to HA and could not complete the study. One participant was excluded from data analysis due to
excessive time between trials (>4 weeks), leaving 20 participants with for final analyses (Figure
2). The duration of hypoxic exposure (165 ± 8 min, PLA; 161 ± 8 min, NIT) and percent oxygen
in the hypoxic chamber (11.6 ± 0.1%, PLA; 11.7 ± 0.1%, NIT) were not significantly different
between treatments (PLA vs NIT; Table 4). Participants had similar measures of hematocrit and
hemoglobin at baseline between both PLA and NIT treatments. HA exposure resulted in similar
significant decreases in SaO2 and ET-CO2 in both PLA and NIT treatments compared to SL (p <
0.05). Symptoms of AMS were greater for NIT (3 ± 2) compared to PLA (2 ± 2) after
approximately 110 min of hypoxia (p = 0.053), although these differences subsided after
approximately 137 min of hypoxia (p > 0.05). Salivary nitrite was significantly greater at HA for
NIT compared to PLA (Table 11; p < 0.05). Likewise, exhaled NO (collected in a subset of
participants, n = 9) was significantly greater at HA for NIT compared to PLA (p < 0.05). In
combination, these data indicate that levels of nitrate/nitrite/NO bioavailability were different
between treatments at HA.
Effect of high altitude on cognitive function
There were no differences in cognitive function at SL baseline between PLA and NIT
treatments (p > 0.05). A significant effect of HA was detected within the memory and
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information processing domains (Table 5). Memory recognition was significantly lower at HA
compared to SL in both PLA and NIT treatments (p < 0.05). This was driven by significantly
greater intrusion errors and significantly lower memory recognition performance in both PLA
and NIT treatments at HA (p < 0.05). Information processing performance (accuracy and RT)
during the verbal interference task was significantly improved in both PLA and NIT treatments
at HA compared to SL (p < 0.05). Emotion recognition index was significantly lower in both
PLA and NIT treatments at HA compared to SL (p < 0.05). Cognitive performance in the
remaining cognitive domains were not affected by HA exposure in either PLA or NIT treatments
(p > 0.05). There were no differences in cognitive function between PLA and NIT at HA (p >
0.05), indicating NIT supplementation was not effective in altering cognitive function at HA.
Effect of high altitude on neurovascular coupling
By design, there were no differences in percent correct and percent incorrect between
treatments (PLA vs NIT) or conditions (SL vs HA) during the Stroop protocol (Table 6). This
was achieved by adjusting inter-trial intervals based on task performance to elicit ≈60% accuracy
(described in the methodology). Additionally, the total number of questions answered, and mean
reaction times were similar between both treatments at SL and HA (p > 0.05). Qualitative data
on mood state self-reported via questionnaire suggested that participants in both PLA and NIT
treatments felt they exerted less effort, had less control, and were less happy during the mentalstress protocol at HA compared to SL (p < 0.05). There were no differences in perceived arousal
or importance of the Stroop task between PLA or NIT treatments or between SL and HA (p >
0.05).
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Cerebrovascular reactivity scores during mental stress were calculated as a measure of
NVC during a cognitive perturbation. For both PLA and NIT treatments, cerebral reactivity to
mental stress (∆PI, ∆mV, ∆Conductance; Table 7), were not different at HA compared to SL (p >
0.05). Carotid diameter reactivity during mental-stress was significantly lower in both PLA and
NIT treatments at HA compared to SL (p < 0.05); the carotid artery dilated less during mental
stress at HA compared to SL. There were no differences in carotid blood pressure, blood flow,
blood flow pulsatility, or stiffness reactivity to mental stress with ascent to HA compared to SL
(p > 0.05; Table 8). Likewise, measures of wave intensity (W1, NA), global wave reflection
(AIX75), and carotid blood pressure changed similarly during mental-stress at SL and HA in
both PLA and NIT treatments (p > 0.05). There were no significant differences in
cerebrovascular reactivity to mental-stress at HA between NIT and PLA treatments (p > 0.05),
indicating NIT did not significantly alter NVC at HA compared to PLA.
Effect of high altitude on cerebrovascular and peripheral vascular function at baseline
There were no differences in cerebrovascular or vascular function between PLA or NIT
treatments at SL baseline (p > 0.05). Cerebral conductance and cerebral blood flow pulsatility in
both PLA and NIT treatments were not different at HA compared to SL (p > 0.05; Table 9).
Mean MCA blood flow velocity for both PLA and NIT treatments was greater at HA compared
to SL (p < 0.05).
Carotid DBP in both PLA and NIT treatments was greater at HA compared to SL (p <
0.05; Table 10). SBP and MAP were similar in both treatments at HA and SL (p > 0.05). Mean
carotid artery diameter and carotid blood flow were greater in both PLA and NIT treatments at
HA compared to SL (p < 0.05). Carotid stiffness tended to be lower in both PLA and NIT
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treatments at HA compared to SL but this was not significant (β-stiffness, p = 0.051; Ep, p =
0.20). Carotid blood flow pulsatility, measures of wave reflection (NA, AIX75), and forward
wave magnitude (W1) were not different at HA compared to SL. Brachial FMD was
significantly lower in both PLA and NIT at HA compared to SL (p < 0.05; Table 11). There
were no differences in reactive hyperemia stimulus, assessed as area under the hyperemic curve
for PLA and NIT at HA compared to SL. There were no significant differences in peripheral or
cerebrovascular measures between PLA and NIT at HA (p > 0.05), indicating NIT
supplementation did not alter vascular responses to hypoxia.
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Chapter V: Discussion
This study investigated the effect of acute dietary nitrate supplementation in the form of
beetroot juice on cerebrovascular and cognitive function at HA. The overarching hypothesis was
that nitrate supplementation would result in greater NO formation and act to increase
vasodilation, blood flow, and oxygen delivery to the cerebrovasculature, thereby optimizing
NVC and attenuating decrements in cognitive performance following rapid ascent to HA. The
primary findings of the study were as follows: although acute nitrate supplementation improved
markers of NO metabolism (i.e. increased salivary nitrate and exhaled NO), acute nitrate
supplementation 1) did not prevent reductions in cognitive function at HA; 2) did not prevent
reductions in NO-mediated vascular reactivity at HA; 3) did not augment carotid or cerebral
blood flow at HA. Thus, targeting NO metabolism with acute dietary nitrate supplementation
may not be efficacious in maintaining cognitive or cerebrovascular function at HA in young,
healthy men.
Ascent to HA and the resulting hypoxemia impairs cognitive function,38 with more
pronounced effects occurring at more severe altitudes.39 This study was conducted at a
simulated altitude of ≈4,700m based on previous reports that the critical altitude to observe
changes in cognitive function is between 4,000-5,000m,133 although some studies have observed
changes well below this threshold.3,41,153 The current study observed significant decreases in
memory function following approximately 2.5 hours of hypoxia. Specifically, there were
reductions in verbal memory and intrusion indexes, resulting from decrements in immediate and
delayed memory accuracy and greater error rates, respectively. These decrements in the memory
domain are consistent with previous reports6,7,52,60,154,155 across a variety of altitudes ranging from
2,800m153 to 9,449m.154 There was also significant dysfunction with regards to emotion
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recognition. Emotion recognition has not previously been assessed at HA, but has recently been
reported to be fundamentally related to general cognition and may play an integral role in the
organization of information processing.156 Other domains of cognitive function may not be
affected by HA. Performance on simple tasks, such as 2-choice RT and finger tapping, is
maintained at HA below 6,000m.32 Indeed, we observed no significant changes in finger tapping
speed, choice RT, or go-no-go tasks. We also observed no effect of HA on verbal learning rate
and executive function and this too is consistent with several previous reports.157-159 Recent data,
obtained after 30-minutes at 5,334m, indicated no significant differences in performance or
complex RT during the Stroop task,160 consistent with our findings. This may suggest that
executive function as a domain may not be sensitive to the acute hypoxia,161 or perhaps requires
longer exposure or more extreme hypoxia to observe effects. Taken together and these findings
confirm general cognitive decrements in select domains under hypoxic conditions.
Proper cognitive function requires continuous, adequate perfusion and oxygen delivery
provided by the cerebrovasculature.10,39,61 NVC is a compensatory increase in blood flow to
brain regions where neurons are active, ensuring adequate blood flow to support neural activity
during cognitive engagement.15 The ability of the vasculature to respond to stimuli,
appropriately vasodilate and increase blood flow is partially dependent on NO, a vasoactive
metabolite released from the endothelium that causes vascular smooth muscle relaxation and
vasodilation.162 There is a decrease in NO bioavailability during acute HA exposure and this
may impair the vasculatures ability to vasodilate, thereby affecting NVC.114,115 In support of this,
our study documented reductions in peripheral endothelial function (brachial FMD) at HA
compared to SL, consistent with one recent publication.163 The carotid artery also dilated
significantly less during mental-stress at HA compared to SL in both treatments, suggesting
37

carotid endothelial dysfunction.164 Thus the goal of this study was to enhance NO availability
during cognitive tasks via acute consumption of dietary nitrate as a means of improving NVC
and cognitive function at HA. Participants consumed a 0.45 g nitrate bolus, a dose which has
previously been used in HA research and reported to significantly increase plasma nitrate and
nitrite.26 Under normoxic conditions, nitrate ingestion has been reported to increase regional
cerebral perfusion in older adults,25 and reduce hyperemic lag times during visual stimulation,30
indicative of improved NVC. Additionally, normoxic data would suggest that nitrate
supplementation can acutely reduce blood pressure,165 and increase brain perfusion25 (although
this is not a universal finding).30,166 Using semi-quantitative measurements of salivary nitrite, we
documented significant increases in nitrite approximately 137 minutes after ingestion and HA
exposure. This finding was corroborated with measures of exhaled NO in a subset of
participants (n = 9). Acute beetroot juice consumption significantly increased nitrite
bioavailability and exhaled NO, although it was not able to prevent reductions in cognitive
function that occurred at HA, nor was it able to prevent reductions in NO-mediated vascular
reactivity or augment NVC.
Despite aforementioned reductions in vascular endothelial function at HA, the results of
this study suggest that NVC was largely maintained in this hypoxic setting. Blood flow is
ultimately determined by changes in vessel diameter and/or flow velocity with optimal flow
delivery (i.e. laminar flow versus pulsatile flow) being affected by regional vascular stiffness.
Impaired mental-stress-mediated carotid dilation did not attenuate carotid or cerebral blood flow
responsiveness during mental-stress since blood flow reactivity was similar at SL and HA
between treatments. Similar mental-stress vascular-hemodynamic reactivity scores were also
observed for carotid stiffness (β-stiffness, Ep) and cerebral vascular tone as indicated by similar
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changes in carotid wave reflections92,93 (AIX75, W1, NA) at SL and HA. Our data revealed a
trend (p = 0.062) for attenuated reductions in carotid mean blood flow velocities during mentalstress. That is, although flow velocity was reduced during mental-stress, it was reduced less at
HA. Slightly higher flow velocities may have compensated for the reduced dilation in
maintaining carotid flow and NVC. Nearly 80% of the common carotid artery blood flow feeds
the internal carotid, which in turn provides approximately 80% of the blood supply to the brain at
rest.167 The carotid reactive hyperemia would beneficially direct blood flow to the cerebral
vessels and maintain oxygen delivery to the brain in hypoxic conditions. Indeed, the carotid
hyperemic response likely fed upstream to the cerebral vessels (i.e. increased CBFv), consistent
with previous findings.57,81,89
One reason NVC may have been maintained at HA may be due to compensatory blood
flow augmentation during the initial hypoxic exposure. Oxygen availability is a fundamental
factor in determining blood flow to target organs such as skeletal muscle or the brain. Hypoxic
conditions result in a hyperemic response,168 the degree of which is proportional to the degree of
hypoxemia with arterial oxygen content as the primary factor eliciting compensatory dilation169
and augmented blood flow.170 Ultimately, the compensatory vasodilation ensures oxygen
delivery is matched to demand in the face of arterial hypoxemia.169 We noted significant
increases in carotid artery dilation and concomitantly increased blood flow during baseline at HA
in PLA and NIT treatments. These findings are congruent with recent, comprehensive studies by
Lewis et al. (2014) aiming to document the acute effects of hypoxia on measures of peripheral
vascular163 and cerebrovascular function at HA.171 In line with our findings, they reported
significant increases in carotid dilation under both normobaric171 and hypobaric hypoxia.163
Although Lewis et. al (2014) assessed carotid function 72-96 hr after ascending to 5,050m during
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an expedition,163 our study was conducted using an acute bout of hypoxia in a normobaric
setting, without potential confounding variables (i.e. fatigue, dehydration or disturbed sleep) and
noted similar vascular changes that were documented under normobaric hypoxic conditions.171
Previous simulated HA studies have reported no dilation of the internal carotid artery after only
15 minutes of hypoxia.172 Together, these data suggest that the carotid vasodilatory response to
hypoxia may not occur until after 15 minutes of exposure172 but before 120 minutes (as measured
in this study) and persists following acclimatization (12-14 days after ascent).163
Overall, our findings suggest that acute nitrate supplementation may not be an effective
therapy to combat cerebrovascular and cognitive responses to HA; NO may not be the sole
modulator of peripheral vascular function under hypoxic conditions. Numerous vasoactive
mediators have been implicated in regulating vasodilation beyond NO including prostacyclin,
endothelium-dependent hyperpolarizing factor, and substance P,173 while reactive hyperemia
may be primarily determined by inward-rectifying potassium channels.174 Additionally, NO
inhibition does not affect FMD responses to prolonged hyperemia.140 This suggests that
sustained hyperemia, comparable to the prolonged hypoxemia-driven hyperemia at HA, is not
NO-dependent. Ascent to HA is associated with increased sympathetic drive and catecholamine
release175,176 which may modulate the cardiovascular response to hypoxia.177 Indeed, recent
findings have indicated that reductions in peripheral endothelial function at HA may be the direct
result of HA-induced sympathoexcitation.163 Lewis et al. exquisitely demonstrated that an α1adrenoreceptor blockade reverses reductions in brachial FMD under normobaric hypoxic
conditions,163 likely explaining the peripheral endothelial dysfunction observed in our study at
HA. Consistent with previous literature, we found significant indications of enhanced
sympathetic activation including, increases in diastolic blood pressure,178 heart rate,179-181 and R40

W1 (a proxy measure of pre-ejection period)136 at HA compared to SL in both treatments. These
data suggest that the peripheral endothelial dysfunction observed at HA may be the result of
increased sympathetic drive rather than reduced NO-availability. The increase in sympathetic
drive may explain why we documented no change in blood pressure, or FMD with nitrate
supplementation, despite the normoxic data supporting these hypotheses mentioned previously.
Although peripheral vascular dysfunction at HA appears to be largely mediated by
sympathetic activation, the factors responsible for the central vascular dysfunction we
documented at HA have yet to be clearly defined. One possibility is that the carotid dysfunction
observed at HA (evident by reduced mental-stress-mediated dilation) may share common
mechanisms with brachial dysfunction, such as increased sympathetic activation or oxidative
stress.163 Recent data, however, submits that the elastic and muscular arteries may respond
differently to the sympathetic activation that occurs with mental-stress and HA. With mentalstress-induced sympathoexcitation muscular arteries (i.e. radial artery) may increase in
stiffness182 while recent unpublished data from our lab indicates elastic arteries such as the CCA
do not change. At HA, administration of a α1-blockade does not alter larger, extracranial vessel
(i.e. internal/common carotid, vertebral arteries) dilation or blood flow,171 suggesting that there
may be differential effects of sympathetic activation on peripheral versus central vessels at HA.
Importantly, although sympathoexcitation does not appear to affect carotid function at rest
during hypoxia, it may still play a role in modulating carotid responses to mental-stress and
NVC. Ultimately, the mechanisms responsible for hypoxia-induced cerebrovascular vasodilation
and hyperemia may be multi-factorial and rely on multiple, redundant pathways similar to those
observed with the vasodilatory responses to exercise.183 A recent review has suggested these
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mechanisms may involve NO, adenosine, PaO2, NVC responses to decreased tissue oxygen, and
anaerobic neuronal metabolism.170
Methodological Considerations
The current study utilized acute ingestion of a nitrate bolus and documented changes in
nitrate-nitrite-NO availability using measures of salivary nitrite and exhaled NO. Exhaled NO
has been reported to be related to AMS symptoms, with lower exhaled NO prevalent in AMS
positive compared to AMS negative individuals.184,185 In the current study, exhaled NO was
collected in a subset (n=9) of participants as an exploratory measure to observe the effect of
nitrate ingestion on pulmonary NO measures at HA. Relating exhaled NO to symptoms of AMS
was outside the scope of the current study. Consistent with previous literature, our data suggests
that exhaled NO does increase acutely following the ingestion of a nitrate bolus, which may be
reflective of salivary nitric oxide formation186 and provide insight into changes in plasma
nitrate.187
Salivary nitrite, which we used as a proxy measure of plasma nitrate availability,
significantly increased following nitrate ingestion at HA. Although this suggests there were
changes in plasma nitrate, it was not directly measured and could be viewed as a limitation since
recent reports suggest concentrations of nitrate may reach 10-fold higher in the saliva than
plasma.188 The dosage used in our study however has been previously used in acute exercise at
HA26 and reported to significantly increase plasma nitrite and nitrate concentrations.26 It is
possible that a greater dose of nitrate might elicit a greater vasoactive response, however it
should be noted that even the acute dose used in the current study elicited undesirable side
effects. Three participants reported severe nausea following consumption of the nitrate, while no
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reports occurred in the PLA treatment group. This resulted in one participant vomiting during
the trial, and one vomiting after leaving the laboratory post-testing. For these reasons, higher
doses of nitrate may have a greater chance of eliciting beneficial effects but should be
approached cautiously as it may make side effects more common or severe. Additionally, nitrate
loading studies have revealed no effects on cerebral oxygenation status,23 indicating that
increased doses may not be more effective.
The timing of measures after nitrate ingestion could also impact findings. The timeline
utilized in the current study was chosen so that cerebrovascular and cognitive testing would
occur at approximately 2 hrs post-nitrate ingestion since previous literature suggests peak plasma
nitrite levels occur between 2-3 hrs post-ingestion (and remain elevated for approximately 2
additional hours).25,132 We believe our dose was successful in manipulating nitrate
bioavailability based on previous research using a similar method of nitrate supplementation26
and the well-documented plasma nitrate/nitrite responses to beetroot juice.165 We do not believe
the ineffectiveness of nitrate in modulating cardiovascular and cognitive function at HA can be
explained by an insufficient nitrate dose or the timing of outcome measures.
This study was conducted under simulated-hypoxia in order to conduct a highlycontrolled investigation on the effects of nitrate on cerebrovascular and cognitive function.
Specifically, this study utilized a normobaric hypoxic chamber, which may have impacted the
effectiveness of nitrate supplementation. Recent data may indicate that nitrate availability may
be different between normobaric and hypobaric hypoxia.189 Faiss et al. (2013) found that plasma
nitrate and nitrite availability decreased in hypobaric hypoxia, whereas they were unchanged
under normobaric hypoxia.189 This suggests that the method of achieving hypoxia may alter the
availability of nitrate/nitrite/NO and thereby the efficacy of nitrate supplementation. If there is
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no decrease in NO-availability in normobaric hypoxic conditions, additional nitrate/NO
availability may not impact blood flow, vascular function, NVC, or cognitive function.
Moreover, some data suggest hypobaric hypoxia and normobaric hypoxia are not equivalent
stimuli190 and hypobaric hypoxia may lead to greater reductions in oxygen saturation and greater
hypoxemia.3 Therefore, different findings may be revealed if this study were repeated under
hypobaric hypoxic conditions.
An alternate explanation may be related to Stroop task training effects.191 Our study
utilized a separate Stroop task as a mental-stress stimulus to assess NVC prior to cognitive
testing. The repeated, additional exposure to the Stroop task may have masked any decrements
in executive function and cognitive flexibility at HA.
The current study was largely powered to detect changes in cerebral blood flow and
memory at HA based on previous literature.7,60,81 The a priori sample size estimations for these
variables resulted in sufficient power as we observed significant differences at HA in both
cerebral and carotid blood flow and memory function. It is, however, possible that some of our
insignificant findings with the ascent to altitude or effect of nitrate may be due to insufficient
statistical power. In order to adequately address this, we conducted post-hoc power calculations
on select cognitive and vascular measures to obtain measures of effect size and power. Effect
size is a statistical measure of the magnitude of difference, or strength of a difference within a
two groups. An effect size of 0.20, 0.50, 0.80 would be considered evidence of a small,
moderate, and large magnitude of difference, respectively.192 Effect size can be combined with
sample size and error probability to estimate power, defined as the probability that the null
hypothesis is correctly rejected. Measures for post-hoc power analyses were selected based on
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1) a priori hypotheses that the particular variable would change with altitude or nitrate and 2)
values appeared to differ between conditions or treatments although not statistically.
Although measures of executive function have been reported to decrease with high
altitude,32 this is not a universal finding.160,161 In the current study, the ability to accurately
navigate a maze (a measure of executive function) was not significantly affected by hypoxia.
Moreover, effect size (PLA, 0.11; NIT, 0.21) and power (PLA, 0.08; NIT, 0.14) were low when
interrogating the effect of altitude on this measure of executive function (Table 12). This
suggests either 1) altitude exposure may not effect executive function, at least in the duration and
degree of hypoxia used in this study; or 2) altitude may not effect this specific executive function
task. Similarly, performance on switching of attention tasks, such as the Trails A-B task, were
expected to change with altitude, however we noted no significant changes in the average
connection time during the Trails task. Post-hoc power analyses indicated that although PLA
had a moderate effect size and power (0.59 and 0.71, respectively), NIT had a small effect size
and low power (0.24 and 0.18, respectively). The data appears to indicate that performance
during the Trails task improved at HA for PLA but was impaired for NIT. Indeed, the effect of
nitrate at altitude on this task was found to have somewhat moderate power (0.45), suggesting
that differential performance between NIT and PLA may have been revealed if we had a larger
sample size (n≈50 for a power of 0.80). The differences in effect size between NIT and PLA
may have been related to the high variability often observed with reaction times.
Nitrate supplementation was expected to enhance blood flow and NVC at HA, although
no such effects were observed in this study. Post-hoc power analyses indicated that the
magnitude of difference between PLA and NIT was minimal with respect to MCA blood flow
reactivity during mental stress (a measure of NVC), with an effect size of 0.07 and power of
45

0.06. Additionally, the effect of nitrate supplementation on carotid blood flow at rest at HA was
found to have a small effect size (0.38) and low power (0.37). This small effect size suggests
that even with a larger sample (n≈55 to achieve a power of 0.80) the effects would likely lack
clinical or physiological relevance. Thus, nitrate supplementation appears to have minimal
effects on blood flow at HA and insignificant differences observed in this study are likely not
related to lack of statistical power.
The cognitive findings of this study may have been affected by: 1) the order in which the
tasks were presented and 2) practice effects that accompany multiple exposures to a single task.
The cognitive tasks used in this study were presented in the same order across all trials and thus
may have altered our cognitive findings and compromised internal validity. Task performance
may be confounded by time when tasks are presented in the same order, such that fatigue or
boredom could affect performance on a given task later in the battery. Although this is a
possibility since the order of tasks was not randomized within this study, we do not believe it
played a large role since post-hoc analyses suggested that performance on tasks in the second
half of the battery was not different from performance in the first half. None the less, future
studies in this area should adopt the proper psychological methodology of randomizing task
order.
Practice effects may have also played a role in our cognitive findings at HA. Practice
effects occur due to repeated exposure to a task and generally improve task performance. These
effects manifest as improved reaction times and accuracy, along with reduced effort to complete
the task.193 The effect of practice on task performance is multifaceted, affecting information
processing speed, response caution, and nondecisional processing time to both repeated and new
stimuli.193 Moreover, it is currently unknown whether these effects are related to familiarity with
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the task itself or the task stimuli, although it is likely combination of both.193 We attempted to
reduce practice effects with the mental-stress Stroop task (used during the assessment of NVC)
by familiarizing participants with the Stroop task prior to experimental testing. We did not,
however, familiarize participants with the cognitive battery prior to experimental trials, thus it is
possible that practice effects may have effected task performance during the cognitive battery.
Specifically, practice effects may explain the significant increase in visual-interference
performance and insignificant change in verbal-interference performance with the ascent to HA.
If a learning effect were present it would have resulted in stepwise increases in performance and
different baseline values between the first and second visit. This, however, was not observed in
the current study as there were no differences between visits at baseline. The Stroop task used
during the mental-stress protocol has been reported to be vulnerable to practice effects,191 thus
repeated exposure to the mental-stress Stroop task may 1) have masked decrements in cognitive
battery verbal-interference performance or 2) explain the improved performance on the cognitive
battery visual-interference task at HA because of their strong similarity to the Stroop task.
Future HA research should attempt to control for practice effects whenever possible by allowing
ample familiarization prior to experimental trials.
Limitations and Future Directions
This study was conducted under simulated normobaric hypoxia in order to design a
highly controlled investigation to isolate the effect of acute nitrate supplementation on cognitive
and cerebrovascular function. This design brings with it some inherent limitations since
participants were not exposed to sleep disturbances, dehydration, physical fatigue, or mentalstress that may accompany expedition-based ascents to HA. Additionally, the potential
differences between normobaric hypoxia and hypobaric hypoxia highlighted previously3,190
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poses a threat to the applicability of our findings to real-life HA scenarios. The computer-based
cognitive battery used in this study has been used in over 180 scientific publications, validated
against traditional paper-and-pencil tests,194 and shows sound test-retest reliability.195 Despite
these strengths, it is possible the specific tasks selected to interrogate each domain (i.e. Maze
task, forward digit span etc.) may not have been sensitive to hypoxia and therefore may not have
detected hypoxia-induced decrements in specific domains. A recent review by Petrassi et al.
(2012) on cognitive function at HA suggests that cognitive and psychomotor deficits reported in
literature are difficult to quantify and reliably reproduce.3 These inconsistencies may be
explained by the subtlety of cognitive decrements at HA, differences in compensatory
mechanisms, methodology, test sensitivity, inter-individual variation, and the role of exercise
which generally compounds the cognitive decrements seen at HA.3
Our study utilized males which limits the results applicability to other populations.
Results may differ if this study was conducted in females based on hormonal differences
introduced by the menstrual cycle and the subsequent timing of measures during the cycle.
Estrogen has been reported to increase endothelial function, assessed by brachial FMD,196
principally through enhanced expression of NO synthase.197 Females, however, may experience
similar decrements in peripheral endothelial function as their male counterparts since
dysfunction appears sympathetically-mediated at HA,163 rather than low-NO mediated. In the
cerebrovasculature, estrogen has been associated with neuroprotective, anti-inflammatory, and
vasodilatory effects, which may also be related to NO production.198 If NO-production is
attenuated in hypoxic environments as previously reported,14,115 females may experience greater
disruption in cerebrovascular hemodynamics because of the loss of estrogen’s protective effects
that are elicited through NO-mediated mechanisms. The effects of estrogen on cognitive
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function appear less defined, as estrogen therapy does not appear effective in reducing incidence
of mild cognitive impairment in postmenopausal women.199 The role of estrogen in cognitive
function at altitude, however, has not yet been investigated and is most likely complex, owing to
estrogens intricate interactions with neurotransmitters systems and dopamine.200 The
participants in the current study were generally young (23 ± 3 yrs) and healthy. However,
investigating the effects of HA on the cognitive and cerebrovascular function is important across
a large range of ages because vascular response to hypoxia may change with age,3 warranting
further investigations. Future research should attempt to elucidate the mechanism responsible
for the reductions in carotid endothelial function at HA, evident in reduced dilation to mentalstress compared to SL.
Strengths of this study should also be noted. This is the first study to investigate the
effect of acute nitrate supplementation on cerebrovascular and cognitive function at HA. Our
study is also the first to apply novel measures of NVC assessed via simultaneous measurements
of TCD, carotid blood flow, and carotid WIA during mental-stress (elicited by a cognitive
challenge) in a highly-controlled hypoxic chamber. The change in hemodynamics during a
mental-stress task that requires cognitive engagement serves as a novel means to assess NVC in
the cerebrovasculature.
Implications
Military deployment in high altitude (HA) environments have increased in mountainous
terrain such as Afghanistan and Northern Iraq.4 These fighting units are often rapidly deployed
to HA for combat operations4 permitting little time to prepare the body for exposure to HAhypoxia. Our data demonstrates that an acute dose of nitrate prior to ascent to HA does not
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significantly alter cognitive function or novel measures of cerebrovascular function and may not
be efficacious as a means to reduce hypoxia-induced cognitive decrements on military personnel,
at least not in the dosage used in this study. Importantly, previous HA nitrate administration
studies have noted significant effects on muscular oxygenation status but not cerebral status,23
and on time trial performance and steady state oxygen consumption,26 suggesting perhaps
differential effects of nitrate supplementation on the skeletal muscle and brain. Recent findings
implicate sympathetic-drive as a contributing factor to the vascular dysfunction observed at
HA163 which may suggest that adrenergic blockades may alter NVC and cognitive function at
HA.
In conclusion, both the NIT and PLA treatments experienced significant increases in
cerebrovascular blood flow, reductions in brachial endothelial function, and decrements in
memory performance at HA compared to SL. Our novel assessment of NVC revealed carotid
artery endothelial dysfunction in both treatments, manifesting as an attenuated vasodilator
response to mental-stress at HA compared to SL. These data provide new insight into endothelial
dysfunction that occurs not only in the periphery but the central vasculature as well while at HA.
Ultimately we found that acute nitrate supplementation does not alter cognitive or
cerebrovascular function at HA compared to a nitrate-depleted placebo.
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Illustrative Materials

Figure 1: Neurovascular coupling under normal conditions (normoxia)
Adapted from Attwell et al. (2010).
nNOS, neuronal nitric oxide synthase; NO, nitric oxide
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Figure 2: Study design.
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Figure 3: Enrollment and participant drop-out.
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Table 1: Cognitive domains.
Domain
Description
Attention/concentration
Ability to focus on/accomplish goal-oriented task

Example test
Calculations/ visual search

Language

Ability to understand and use oral/written language. Word search/ fluency

Visiospatial skills

Ability to comprehend shapes/forms and their
interpretation
Ability to perform gross/fine motor skills

Reproduction of shapes/
images
Peg board, finger tapping test

Ability to store/retrieve information (short/long
term/semantic memory)
Ability to correctly orient date, place, name

digit span/free recall

Psychomotor skills
Memory
Orientation

Ability to conceptualize, evaluate, and complete
goal-oriented tasks
Components
Information processing
Attentional control
Cognitive flexibility
Working memory
Adapted from Davis et al. 2013, Logue et al. 2013, Burnett et al. 2013.

Orientation task

Executive function
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Reaction time
Stroop, PASAT
Stroop, Trails B
Digit span forward

Table 2: Effects of HA on cognitive performance.
Study
Design

Tests

Cognitive domain

Results

Crow et al. (1971)

S-HA; 610 m, 2438 m, 3658 m

Digit recall

Memory

↓ Accuracy at peak

Bolmont et al. (2000)

S-HA; sea level to 8,848 m in 31
days

Binary visual RT

Executive function

No change

Peg board task

Psychomotor skills

↓ Motor skills

Dykiert et al. (2010)

E-HA; 76 m to 5,565 m in 17 days

4-Choice RT

Executive function

↓ CRT

Wang et al. (2013)

E-HA; 402 m to 3,561 m in 1 day

PASAT

Executive function

↓ Performance

DSST

Executive function

↓ number correct (ns)

Free recall
OST

Memory
Executive function

↓ Word recall
No change

McCarthy et al. (1995)

S-HA; 2134 m, 3658 m

RT

Executive function

↑ RT, ↓ accuracy

Du et al. (1999)

S-HA; 300 m, 2800 m, 3600 m,
4400 m

Memory tasks

Memory

↓ Accuracy at 4,400 m

van der Post et al. (2002)

S-HA; SaO2 97%, 90%, 80%

Word recognition

Memory

↓ Accuracy at SaO2 80%

Corsi block tapping
Visual search

Memory
Executive function

No change
No change

Binary visual RT

Executive function

↓ Accuracy, ↑ RT at SaO2 80%

Auditory memory
Dexterity
4-Choice RT

Memory
Psychomotor skills
Executive function

↓ Performance
↓ Performance
↓ Accuracy, ↑ RT

Visual perception

Visiospatial skills

No change

Li et al. (2012)

E-HA; <300 m to 3,900 m within 5
days

S, simulated; E, expedition; HA, high altitude; SaO2, arterial O2 saturation; RT, reaction time; PASAT, paced auditory serial addition test; DSST,
digital symbol substitution test; OST, operation span task; ns, non-significant
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Table 3: Descriptive characteristics (n = 20).
Mean ± SD
Age (yrs)
Height (cm)
Weight (kg)
BMI (kg/m2)
Body fat (%)
Hematocrit (%)
Hemoglobin (g/dl)

23 ± 3
181.1 ± 5.8
79.82 ± 9.72
24.3 ± 3.0
13.3 ± 6.8
43 ± 3
14.7 ± 1.5
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Table 4: Time at high altitude, blood measures, and AMS across condition (mean ± SD).
Placebo
Nitrate
Total time at HA (min)
165 ± 8
161 ± 8
%O2 at cognitive testing
11.6 ± 0.1
11.7 ± 0.1
Baseline hemoglobin (g/dL)
14.5 ± 0.9
14.3 ± 1.1
Baseline hematocrit (%)
42 ± 3
43 ± 3
AMS, 110 min
2±1
3±2
AMS, 137 min
3±2
3±2
HA, high altitude; vasc, vascular testing; cog, cognitive testing; AMS, acute mountain
sickness score.
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Table 5: Cognitive performance and reaction times by cognitive domain across condition and altitude (mean ± SD).
Placebo
Domain
Task
Construct
SL
HA
Memory
Memory Recognition Learning Rate
0±1
0±1

Nitrate
SL

HA
0±1
71 ± 10*

75 ± 9

70 ± 10*

0±1
75 ± 5

5±9
7±1

10 ± 10*
7±2

5±5
7±1

9 ± 10*
6±1

9±2

9 ± 3^

9±2

7 ± 3^

560.29 ± 200.25
2±5
1±1
38783 ± 6742
1508 ± 285
0±1
200 ± 25
343.35 ± 73.64

518.56 ± 127.83
2±2
1±1
35235 ± 6463
1382 ± 258
1±1
199 ± 23
346.52 ± 31.85

467.20 ± 69.27
1±2
0±1
38765 ± 7160
1483 ± 274
1±2
206 ± 23
328.72 ± 34.56

538.91 ± 185.50
3±6
1±1
40163 ± 11671
1580 ± 455
1±1
197 ± 22
350.52 ± 26.52

17 ± 5
1186 ± 321
17 ± 4
1156 ± 278
7±3
114988 ± 42270
94322 ± 38855
30 ± 14
14 ± 8
292.02 ± 44.96
5±4

20 ± 4*
969 ± 156*
17 ± 3
1146 ± 212
8±3
113379 ± 52528
94159 ± 53061
28 ± 11
12 ± 5
282.58 ± 60.81
5±3

17 ± 5
1108 ± 214
18 ± 5
1139 ± 285
8±2
107712 ± 32708
88668 ± 30494
29 ± 12
13 ± 7
287.57 ± 44.13
5±2

19 ± 5*
1056 ± 306*
17 ± 5
1124 ± 208
8±2
117845 ± 42424
97255 ± 38098
31 ± 10
15 ± 7
274.77 ± 44.03
7±3

1±2
1±2
1±3
175.42 ± 8.96
172.77 ± 11.06*
176.35 ± 6.23
1671.38 ± 318.10
1593.84 ± 518.05
1620.17 ± 281.33
SL, sea level; HA, high altitude; scr, score; int, intrusions; RT, reaction time; Visu-Int, visual interference; Verb-Int, verbal interference
* p < 0.050 vs within-treatment SL; ^ trend, p < 0.100 vs within-treatment SL

2±3
170.18 ± 11.20*
1528.67 ± 256.00

Verbal Memory Index
Verbal Intrusion Index
Working Memory
Capacity

Digit Span
(Forward)

Recall Span (forwards)
Trials Correct (forwards)

Attention and
Concentration

Continuous
Performance Test

RT (ms)

Information
Processing
Efficiency

Switching of
Attention (Part 2)

Response Speed
Information
Processing
Efficiency

Motor Tapping
Choice RT
Visu-I (Word)
Verb-I (Color)

Executive
Function

Maze

Impulsivity

Go/No-Go

Emotion
Identification

Emotion Recognition

Commission Errors
Ommission Errors
Duration (ms)
Connection Time (ms)
Accuracy
Tapping Speed
Choice RT (ms)
# Correct w/ Visu-Int
RT w/ Visu-Int (ms)
# Correct w/ Verb-Int
RT w/ Verb-Int (ms)
Trials Completed
Completion Time (ms)
Path Learning Time (ms)
Accuracy
Number of Overruns
Speed
Commission Errors
Ommission Errors

Emotion Recognition Index
Average RT (ms)
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Table 6: Stroop task performance and emotional responses across treatments and altitude (mean ± SD).
Placebo
Nitrate
SL
HA
SL
HA
Total questions
110 ± 8
110 ± 9
112 ± 8
112 ± 8
Correct (%)
67 ± 13
64 ± 12
67 ± 15
67 ± 13
Incorrect (%)
33 ± 13
36 ± 12
33 ± 15
33 ± 13
Mean correct RT
1044 ± 165
1033 ± 172
998 ± 141
992 ± 132
Happiness
7±1
6 ± 2*
7±1
6 ± 1*
Perceived control
7±1
7 ± 2*
7±1
6 ± 2*
Arousal
4±2
4±2
3±1
4±2
Effort
23 ± 2
22 ± 4*
23 ± 2
21 ± 5*
Importance
24 ± 3
22 ± 3
24 ± 3
22 ± 4
SL, sea level; HA, high altitude; RT, reaction time
* p < 0.05 vs within-treatment SL
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Table 7: Cerebral mental-stress-mediated reactivity across treatments and altitude (mean ± SD).
Placebo
Nitrate
SL
HA
SL
HA
Mean velocity (m/s)
+5±6
+5±9
+7±7
+6±7
PI
-0.01 ± 0.06
-0.01 ± 0.10
-0.04 ± 0.08
-0.03 ± 0.07
Conductance
-0.02 ± 0.08
+ 0.01 ± 0.10
-0.04 ± 0.10
+ 0.02 ± 0.12
HR (bpm)
+ 8 ± 11
+7±8
+6±8
+5±7
SaO2 (%)
+0±2
+0±5
+0±2
+1±4
SL, sea level; HA, high altitude; PI, pulsatility index; HR, heart rate; SaO2, arterial oxygen
saturation.
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Table 8: Carotid artery mental-stress-mediated reactivity across treatments and altitude (mean ± SD).
Placebo
Nitrate
SL
HA
SL
HA
SBP (mmHg)
+6±9
+ 5 ± 10
+1±8
+ 4 ± 11
DBP (mmHg)
+ 10 ± 6
+4±7
+6±6
+7±8
MAP (mmHg)
+9±6
+5±6
+4±4
+5±8
Mean diameter (mm)
+ 0.16 ± 0.15
+ 0.00 ± 0.20*
+ 0.17 ± 0.19
+ 0.07 ± 0.26*
-1
MnV (cm∙s )
- 0.8 ± 3.1
- 0.4 ± 3.6^
- 2.0 ± 3.6
+ 0.5 ± 3.1^
PI
- 0.01 ± 0.17
- 0.01 ± 0.25
- 0.09 ± 0.24
- 0.07 ± 0.24
Blood flow (ml∙s-1)
+ 16.3 ± 66.7
- 10.9 ± 91.6
- 0.8 ± 67.6
+ 28.3 ± 90.2
β-stiffness
- 0.7 ± 1.0
- 0.2 ± 1.6
- 0.7 ± 1.2
- 0.4 ± 1.2
Ep (kpa)
- 4 ± 14
- 2 ± 21
- 6 ± 15
- 3 ± 15
AIX75 (%)
+ 9 ± 12
+ 5 ± 16
+ 7 ± 10
- 3 ± 15
W1 (mmHg∙m∙sec-3)
+ 0.69 ± 7.06
+ 0.03 ± 5.11
- 1.15 ± 4.40
+ 0.61 ± 7.17
NA (mmHg∙m∙sec-2)
- 17.605 ± 45.738
+ 5.748 ± 22.545
- 17.326 ± 43.514
- 14.390 ± 51.243
SL, sea level; HA, high altitude; SBP, systolic blood pressure; DBP, diastolic blood pressure; MAP, mean
arterial pressure; PI, pulsatility index; Ep, elastic modulus; AIX75, augmentation index at 75 bpm; W1, forward
wave magnitude; NA, reflected wave magnitude.
* p < 0.050 vs within-condition SL; ^ trend p = 0.062 vs within-condition SL
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Table 9: Cerebral hemodynamics at baseline across treatments and altitude (mean ± SD).
Placebo
Nitrate
SL
HA
SL
HA
-1
Mean velocity (m∙s )
66 ± 15
74 ± 20†
68 ± 16
75 ± 18†
PI
0.83 ± 0.14
0.78 ± 0.11
0.84 ± 0.17
0.79 ± 0.13
Conductance
0.80 ± 0.19
0.87 ± 0.26
0.82 ± 0.19
0.90 ± 22
HR (bpm)
56 ± 9
64 ± 8†
54 ± 7
64 ± 11†
ETCO2 (mmHg)
39 ± 2
33 ± 2†
39 ± 3
34 ± 2†
SaO2 (%)
98 ± 2
75 ± 6†
98 ± 2
75 ± 7†
SL, sea level; HA, high altitude; PI, pulsatility index; HR, heart rate; ETCO2, end-tidal
CO2; SaO2, arterial oxygen saturation
† p < 0.05 vs within-treatment SL
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Table 10: Carotid measures of vascular function during baseline and mental stress across condition and altitude (mean ± SD).
Placebo
Nitrate
SL
HA
SL
HA
SBP (mmHg)
106 ± 11
108 ± 11
107 ± 7
106 ± 11
DBP (mmHg)
68 ± 6
74 ± 7†
70 ± 6
71 ± 8†
MAP (mmHg)
83 ± 7
87 ± 6
84 ± 6
85 ± 9
Mean diameter (mm)
5.91 ± 0.46
6.60 ± 0.47†
5.75 ± 0.48
6.54 ± 0.45†
PI
1.99 ± 0.33
1.92 ± 0.42
2.09 ± 0.31
1.96 ± 0.31
-1
Blood flow (ml∙s )
621.0 ± 89.9
786.5 ± 139.7†
602.0 ± 88.1
746.5 ± 126.3†
β-stiffness
4.4 ± 1.2
3.7 ± 1.4^
3.9 ± 1.0
3.5 ± 1.1^
Ep (kpa)
50 ± 14
45 ± 19
45 ± 12
41 ± 15
R-W1 (ms)
112 ± 22
106 ± 19
119 ± 28
106 ± 17
AIX75
-27 ± 12
-29 ± 11
-28 ± 13
-29 ± 13
W1 (mmHg∙m∙s-3)
10.61 ± 5.50
12.51 ± 8.19
9.87 ± 4.88
11.64 ± 5.39
NA (mmHg∙m∙s-2)
66.532 ± 62.625
54.054 ± 68.902
54.335 ± 46.900
55.940 ± 42.460
SL, sea level; HA, high altitude; SBP, systolic blood pressure; DBP, diastolic blood pressure; MAP, mean arterial pressure; PI,
pulsatility index; Ep, elastic modulus; AIX75, augmentation index at 75 bpm; W1, forward wave magnitude; NA, reflected
wave magnitude.
† p < 0.05 vs within-treatment SL; ^ p = 0.051 vs within-treatment SL
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Table 11: Measures of nitric oxide bioavailability and brachial vascular measures across treatments and altitude (mean ± SD).
Placebo
Nitrate
SL
HA
SL
HA
Salivary nitrate (AU)
0.1 ± 0.2
0.2 ± 0.3
0.1 ± 0.2
2.7 ± 1.0 §*
Ex NO (ppb; n = 9)
19 ± 5
20 ± 5
16 ± 6
35 ± 9 §*
Brachial SBP (mmHg)
114 ± 10
114 ± 10
113 ± 9
112 ± 12
Brachial DBP (mmHg)
68 ± 6
74 ± 7*
70 ± 6
72 ± 8*
Brachial MAP (mmHg)
83 ± 7
86 ± 6
84 ± 6
84 ± 8
Average BL diameter (mm)
4.00 ± 0.48
4.07 ± 0.43
3.95 ± 0.47
4.08 ± 0.45
FMD (%)
6.22 ± 3.62
4.87 ± 3.22*
8.13 ± 3.14
5.52 ± 3.14*
Reactive hyperemia AUC
697.14 ± 221.81
736.59 ± 161.74
675.09 ± 194.39
726.36 ± 249.41
SL, sea level; HA, high altitude; Ex NO, exhaled nitric oxide; SBP, systolic blood pressure; DBP, diastolic blood pressure;
MAP, mean arterial pressure; BL, baseline; FMD, flow mediated dilation; AUC, area under the curve.
§ p < 0.05 vs Placebo-HA; * p < 0.05 vs within-treatment SL
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Table 12: Effect sizes and statistical power for the effect of altitude and nitrate across select variables.
Effect of HA
Effect of nitrate at HA
Placebo
Nitrate
Placebo vs Nitrate
Effect size
Power
Effect size
Power
Effect size
Power
Variable
Switching-attention connection
time
0.59
0.71
0.24
0.18
0.43
0.45
Maze accuracy
0.11
0.08
0.21
0.14
0.29
0.24
MCA blood flow
0.77
0.90
0.96
0.98
0.07
0.06
CCA blood flow
1.49
1.00
1.25
1.00
0.38
0.37
∆MCA blood flow
0.03
0.05
0.14
0.09
0.07
0.06
∆CCA blood flow
0.23
0.16
0.26
0.20
0.26
0.20
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Appendix 1

EXERCISE SCIENCE
820 COMSTOCK AVENUE
201 WOMEN’S BUILDING
SYRACUSE, NY 13210
(315)-443-2114
Effects of Beetroot Juice Supplementation on High Altitude Cognitive and
Vascular Function

Principal Investigator: Kevin Heffernan, Ph.D.
Telephone: 315-443-9801
Email: ksheffer@syr.edu
IRB Protocol #: 13-370
We are inviting you to participate in a research study. Involvement in the study is voluntary, so
you may choose to participate or not to participate. This sheet will explain the study to you and
please feel free to ask questions about the research if you have any. I will be happy to explain
anything in detail if you wish.
Purpose
Normal brain function relies on oxygen supply. At high altitudes the amount of oxygen
you inhale and deliver to your body decreases, impairing your body’s ability to function normally.
This negatively affects your ability to think and process problems. Research has shown that at
high altitude your reaction time slows down, you lose some of your fine motor skills and your
ability to remember things is decreased. This may be the result of decreased blood flow and
oxygen delivery to the brain when you are thinking or processing information. These effects are
very problematic for people who are exposed to high altitude, such as military personnel or
mountaineers.
The purpose of this study is to investigate whether or not supplementing with beetroot juice
before ascending to high altitude will increase oxygen delivery to the brain when you are thinking
and performing cognitive tasks, resulting in increased brain function. Beetroot juice is a natural,
vegetable juice that comes from beets, a vegetable commonly found in salads. It has high amounts
of nitrate, a molecule that can be broken down into the body into a compound that can cause your
blood vessels to expand and deliver more blood and oxygen. In this study, we will have you
perform a series of cognitive tests and will measure your blood vessels both in a normal
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environment (i.e. no change in altitude) and in a simulated high altitude chamber after consuming
beetroot juice. This will be done over 3 visits that are described below. Understanding if a natural
supplement, like beetroot juice, can help brain function at high altitude has important benefits for
the health and safety of people who work at high altitude.
Who can participate?
• Men and women between the ages of 18-30.
Do I have to participate?
• Your participation in this study is voluntary, which means you get to decide whether or not you
want to participate
• Make sure that you read this entire form before making a decision and take as much time as you
need.
• Feel free to ask as many questions about the study as you want. If you do not understand a term
in the form, ask, and a researcher will explain it for you.
• If you decide to participate in the study you will be asked to sign a consent form.
• Do not sign the consent form until all of your questions have been answered and you understand
what will happen in the study.
• Your signature means that you agree to participate in this study.
• You can ask for a copy of this form whether or not you agree to take part in the study.
• Your decision not to be in this research study will not result in any loss of benefits to which you
are otherwise entitled.
Can I Withdraw From The Study Once It Has Started?
• At any time you may remove yourself from the study without giving any reason.
• If you are a student, withdrawing from the study will not affect your grade in courses in any way.
What Can I Expect From Participating?
For this study, you will need to visit the Human Performance Laboratory and Altitude Simulation
Laboratory, located in the Women’s Building at Syracuse University once for study screening and
twice for the study. The screening will take about 45 minutes and each study visit will take
approximately 4 hours.
• At the screening visit you will be asked to fill out and sign this consent form, Health History
Questionnaire, and a vision and colorblindness examination. Additionally, we will measure your
height using a large ruler that is mounted against a wall. With your shoes still off, we will ask
you to stand upright with your back against this wall for a few moments as we measure your
height.
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• We will ask you to give us a small urine sample so that we can check the function of your
kidneys. We will provide a small sample container and escort you to the restroom.
• We will then estimate your body composition (percent body fat) using a BodPod that will require
you to wear tight fitting, minimal clothing for greatest accuracy in estimations. You will be
asked to sit quietly in a chamber that resembles a giant egg for approximately two, 60-second
intervals. This machine measures your body volume to estimate body fat.
• We will also have you perform a brief cognitive test to measure basic brain function. We will
also have you practice one on the computer in order to become familiar with it.
• We will take you down to the altitude chamber (it will not be on, so we will still be at normal
altitude) to familiarize you with the chamber and answer any questions you might have. In total,
the screening visit will take approximately 45 minutes.
• We will send you home with a 3-day dietary recall survey and a list of certain foods that we will
request you avoid for the 3-4 days before each of your next scheduled visits.
• For the two study visits we will ask you to arrive not having eaten within the past 3 hours (we
will provide a snack (granola bar and juice) at the end of testing). Blood pressure can be affected
by exercise and consuming food, caffeine or alcohol. Therefore, we will please ask you to refrain
from exercising or consuming alcohol or caffeine (including caffeinated coffee, tea, soda or
energy drinks) on the day that you will come into the lab.
• You will be asked to lie down and rest for 10 minutes. Following rest, we will place a blood
pressure cuff around upper arm (bicep). We will also measure your heart rate using ECG. Three
electrodes (stickers) will be placed on you. One will be placed on your left shoulder, one on the
lower left rib and one on the lower right rib. These stickers can be easily peeled off when the
study is over. Following this we will check blood pressure in your wrist (radial artery), neck
(carotid artery) and upper leg (femoral artery). To do this, we will use a very sensitive blood
pressure machine that looks like a pen with a little watch battery at the end. We will gently place
this pen on top of your skin over wrist followed by your neck and upper leg. This measurement
is non-invasive (no needles/no blood) and will take less than 10 minutes. From this information,
we can estimate artery elasticity.
• We will measure how reactive your vessels are by imaging the artery in your arm using an
ultrasound probe which is a small device (about the size of a deodorant stick) that we will set on
the surface of your arm. We will inflate a cuff around your forearm to about 200 mmHg, similar
to the highest pressure used when your blood pressure is measured at the Doctor’s office, for 5
minutes. We will then release your artery and measure how it responds to the release in blood
flow.
• Next we will measure your neck blood flow and brain blood flow using two non-invasive (no
needles, no blood) techniques, Doppler ultrasound and blood flow sensors. Ultrasound probes
will be placed on your neck and on the side of your face (between eye and ear) to assess neck
artery stiffness and blood flow and brain blood flow. Blood flow sensors will be placed on the
forehead to assess brain blood flow.
• Then we will give you a cognitive task to complete, which will be displayed on a monitor. You
will use hand clickers to respond to questions on the monitor for 5-10 minutes. During these
cognitive tasks we will continue to measure artery stiffness and blood flow using the ultrasound
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probes and blood flow sensors. This test will give us information about how your arteries react
to the thinking required to answer the cognitive test. This 4 minute test will be repeated after a
short break, requiring a total of about 15 minutes.
• We will also measure your hemoglobin and hematocrit by obtaining a small drop of blood from
your fingertip (finger prick).
• We will also have you stick a small test strip under your tongue for 3-5 seconds to absorb a small
amount of saliva. This test is designed to give us a general idea of how much of a certain molecule
you have present in your saliva. We believe this molecule (nitrite) may have an effect on your
blood vessels.
• We will have you exhale into a mouthpiece for a brief amount of time. The mouthpiece will be
attached to a small machine (approximately the size of a mini gum ball machine) that measures
the amount of a certain molecule (nitric oxide) in your lungs. We think this molecule may affect
your blood vessels.
• You will complete a computer-administered cognitive and mental status tests. These tests may
require between 25-30 minutes for completion. You will be seated at a computer for these tests,
which are designed to assess your memory, attention, reflexes and problem solving skills. This
test covers a wide range of brain function because we want to see what part of your brain function
might change with exposure to high altitude.
• Before beginning the next portion of the visit you will be permitted a bathroom break. You will
then be given a small, approximately 2.3 ounces (70 mL) juice drink to consume before entering
the altitude simulation chamber. You will relax in the altitude chamber at an approximate
altitude of 14,000 ft for 1 hour and 45 minutes. At high altitudes there is less oxygen available
for your body, so your body compensates by increasing the rate of your breathing and how
quickly your heart beats. Understand that if you begin to feel these symptoms, they are natural
and are not dangerous.
• During this time we will attach a clip to your finger and will also attach a small cord to your
forehead using a headband in order to measure blood oxygen saturation. Every 30-minutes you
are in the altitude chamber we will give you a short survey to see how you are feeling physically.
• After 1 hour and 45 minutes, we will conduct the same measures we did outside of the chamber,
finger stick blood sample, saliva strip testing, blood pressure and blood flow measures, and
cognitive testing.
• Upon completion of the testing we will escort you out of the altitude chamber and will take a
few final blood pressures on your upper arm and monitor your oxygen saturation until it has
reached your pre-chamber levels. At this point you will be permitted to leave.
• If you wish to withdraw from the study at any time you are free to do so.
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Estimated study timeline for participants.
Visit 1 (≈ 45 min)
Item
Consent form

Visit 2-3 (≈ 4 hours each)

Time (min)
15

Item

Time (min)

Blood pressure
10

Color vision testing
Height

Blood flow
5

Urine sample

Vascular reactivity

10

Finger stick

Body composition

5

Expiration test

Cognitive test practice

10

Saliva test strip

Cognitive testing

10

Cognitive testing

5

45

Consume juice beverage
Enter altitude chamber

105

Repeat above procedures
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Can I be excluded from participation for any reason?
• Based on answers to the above mentioned health history questionnaire, you may be excluded
from the study. If you regularly experience any signs or symptoms that suggest you may have a
medical condition and your health care provider is not aware that you are experiencing these
symptoms, we will exclude you from the study and ask that you contact your health care
provider. We also will exclude you if you have known allergies to beets, a primary ingredient
of the juice drink we ask you to consume, or if you have a history of losing consciousness.
• If you are experiencing any signs or symptoms of a serious/significant health condition at the
time of consent (i.e. severe chest pain, leg pain, dizziness, feelings of heart palpitations) we will
contact emergency medical services immediately and you will not be able to participate in the
study.
What Benefits Can I Expect From Participating?
• A benefit from this study is helping us understand if we can increase the cognitive performance
of those who work in high altitude conditions.
• You may feel good about helping others with their research study by participating in this
research study.
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• You will receive information on your blood pressure, body composition,
hemoglobin/hematocrit and cognitive function.
• These tests are not being used to diagnose a problem (NOT for medical/clinical purposes).
These tests are for research purposes only. If you have high blood pressure we will inform
you to go the university health center or go see your health care provider.
Are There Any Potential Risks From Participating In This Study?
• There are some risks associated with portions of this study.
• We will use a small amount of gel to help us measure your brain blood flow. There is a small
risk that this gel may get in your eye. To protect against this happening, we will use the least
amount of gel possible to obtain our measurements. Also, all measures will be made with you
in a stationary position, lying down. We will remind you to remain still as we take this
measure to ensure that the gel does not come into contact with your eye. If gel does come into
contact with your eye, it may cause slight discomfort (slight drying) but it is not permanent.
The gel is water soluble and actually designed to be used for eye exams therefore it rinses out
easily. We will escort you quickly to an eye fountain to rinse out your eye.
• Communicating with the researcher throughout the protocol will reduce risks.
• If at any point you are uncomfortable or feel pain anywhere, please tell us immediately.
• You may experience discomfort from the finger stick to test your blood lipids, hematocrit and
hemoglobin. This will only be done two or three times and no more than that. We will use
different fingers each time to reduce discomfort. If desired we can also place ice on the finger
prior to the finger stick to reduce discomfort from the pinch.
• There is a small risk of infection associated with the finger stick. However, we will reduce this
risk by ensuring that equipment is clean and sterile and the finger stick technician will wear lab
coat, gloves, will clean the finger with alcohol swabs and will clean the area with a disinfectant
wipe afterwords.
• There is some risk of discomfort with the measurement of vessel reactivity. This technique
uses a blood pressure cuff inflated around the forearm to pressures around 200 mmHg. This
pressure may become uncomfortable over the 5 minute duration. You may feel as though your
arm is “falling asleep,” and may feel a numb or tingling sensation in the hand. This feeling
will subside almost immediately when the cuff is released from the forearm.
• There is some risk of developing a headache and nausea at high altitude, known as acute
mountain sickness (AMS). Importantly, this occurs more frequently with prolonged exposure
to high altitude and intense exercise, the duration of the current study is short enough (and does
not include exercise) so we do not anticipate the development of these complications. As a
precautionary measure, however, we will monitor your blood oxygen saturation and administer
a survey to document any symptoms of acute mountain sickness. If you end up presenting
multiple symptoms based on the survey we may remove you from the altitude chamber.
Additionally, we will monitor your blood oxygen saturation until it returns to normal values
after exiting the chamber.
• There is a small risk of losing consciousness after entering the altitude chamber. We will
minimize this risk by having you sit upon entering the chamber while your body initially
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adjusts to the changes in altitude and by keeping a technician nearby during any major changes
in body position (i.e. moving from lying down to standing). Additionally, we will investigate
whether you have a history of losing consciousness prior to testing. If you have a history of
losing consciousness you may be excluded from participating.
• There is minimal risk with consuming beetroot juice. It is possible you may experience gastric
distress if you are allergic to beetroot juice. Beetroot juice has been shown to lower blood
pressure after consuming it. This could potentially result in light-headedness or dizziness upon
changes in body position (such as lying to standing). These risks are minimized because you
will not be exercising while in the altitude chamber. As a precautionary measure, we will
measure and monitor your blood pressure following the conclusion of testing and exiting the
altitude chamber. You will be released once blood pressure has returned to normal values to
pre-chamber values.
• In the event of illness or physical injury resulting from taking part in this research study,
medical treatment will not be compensated for. You will be responsible for any costs not paid
by your insurance company. No other compensation is offered by Syracuse University. You
have not waived any of your legal rights by signing this form.
Are There Any Costs?
•

There will be no costs to you for participating in this study.

Who Can See Information About This Study?
• The research records from this study will be confidential. Confidentiality means that it is our
responsibility to keep any information you provide private and safe.
• Only members of the trained research staff for this study with training in research ethics may
look over your research records.
• The paperwork, results and records will be kept in a locked filing cabinet that only the
researchers with training in research ethics will have access to.
• You will be given a study identification number (coded numbers, known only by primary
researchers) and this will be entered into all research computers used to collect your blood
pressure and blood flow. Your name will not appear anywhere on these computers or the data
output from these computers.
• All information stored on computers requires a password access it. Only members of the
research team with training in research ethics will have this password.
• The data and research record will be stored for up to 10 years.
• Your individual results will not be used in any way (we will average all results and display
group averages only when presenting findings in papers and presentations)
What Are My Rights In This Study?
•

If at any point you wish to withdraw yourself from the study you may.

•

You do not give up any of your legal rights by participating in this study.
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Who Can I Contact For Questions Or More Information?
• If there are research related injuries or if you have any questions, concerns, or complaints about
this study at any time, please feel free to contact:
o Dr. Kevin Heffernan at ksheffer@syr.edu or call his office at 315-443-9801.
• If you have any questions about your rights as a research participant, you have questions,
concerns, or complaints that you wish to address to someone other than the investigator, if you
cannot reach the investigator, or have experienced research related injuries, contact the
Syracuse University Institutional Review Board at 315-443-3013.
By signing below you indicate that you have read and fully understood this informed consent form.
You are fully aware of the purpose and procedures of this study as well as the risks, discomforts,
and benefits associated with the experimental protocol and that you sign this document freely and
voluntarily.
All of my questions have been answered, I am 18 years of age or older, and I wish to participate
in this research study. I have received a copy of this consent form.
_________________________________________
Signature of participant

_________________________
Date

_______________________________________
Printed name of participant
_________________________________________
Signature of researcher
_________________________________________
Printed name of researcher
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_________________________
Date

Appendix 2

Human Performance Lab Health Screening Form
Date__________
Age _______
Gender ______
Please answer the following questions as honestly as you can. Your patterns of responses will determine
whether you may participate in the study.

Known Diseases (Medical Conditions)
1. List the medications and dietary supplements you take on a regular basis. (Include
prescription and non-prescription, aspirin, vitamins/minerals, nutrition supplements
[Ensure, Boost, etc.])
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________

2. Has your health care provider ever told you have diabetes?
3. Do you have acute or terminal illness (if so, please explain below)?

No
No

Yes
Yes

___________________________________________________________________________
_
4. Have you ever had a stroke, heart attack or heart trouble?

No

Yes

5. Has your health care provider ever told you that you have a heart murmur? No

Yes

6. Have you had a head injury in the past 3 months?

No

Yes

7. Do you have asthma /take asthma medication?

No

Yes

8. Has your health care provider ever told you that you have
kidney or liver disease?

No

Yes

9. Has your health care provider ever told you that you have
chronic pulmonary or respiratory disease?

No

Yes

10. Has your health care provider ever told you that you have
peripheral artery disease?

No

Yes

74

11. Has your health care provider ever told you that you have
high blood pressure?

No

Yes

12. Has your health care provider ever told you that you have
high cholesterol?

No

Yes

13. Do you smoke cigarettes on a daily basis?

No

Yes

No

Yes

No

Yes

If yes to #13, how many packs per day _________________
If yes to #13, how long have you been smoking _________________

14. Have you lost or gained weight in the previous 6 months?
If yes, how much weight? _______
15. Has a first degree relative (e.g. father, mother, sister, brother, or child)
suffered from a heart attack or diagnosed cardiovascular disease?

Relative

Age

Did they pass away?

16. Do you often have pains in your heart, chest, neck, jaw, arms or other areas
especially during exercise?

No

Yes

No

Yes

17. Do you regularly get pains in you calves or lower legs during exercise
which are not due to soreness or stiffness?

18. Do you experience swelling or accumulation of fluid in or around your ankles?
No

Yes

19. Do you often feel faint or have spells of severe dizziness during exercise? No

Yes

20. Do you often get the feeling that your heart is beating faster, racing,
or skipping beats, either at rest or during exercise?
21. If you answered YES to question(s) 17-21, does your health care provider
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No

Yes

know that you have this/these symptom(s)?

No

Yes

22. If you answered YES to question(s) 16-20, are you currently experiencing this/these
symptom(s) RIGHT NOW?
Yes

No

23. With which hand do you write?

Left

Right

24. How do you define your race/ethnicity? ___________________________________

25. What is the highest grade/level of schooling/education completed?
8th Grade

Some HS

HS

some college

college

graduate school

26. Do you have a known allergy to beets?

No

Yes

27. Do you know of any reason you should not travel to high altitude?

No

Yes

If you answered YES to question 27, please explain below.
______________________________________________________________________

28. Have you traveled to any location above >2,500 m (8,200 ft; i.e. higher

No

Yes

than Denver, CO) in the past 2 years?
If you answered YES to question 28, please explain below.
_______________________________________________________________________
29. About how many hours of sleep did you get last night?
__________________________________
30. Please describe your current physical activity:
Mode: resistance exercise, running, cycling, swimming, other _____________________
________________________________________________________________________
Sports: _______________________
Days per week _________________

Minutes per day __________________
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31. Additional:
Please circle all that apply
Allergies

Fibromyalgia

Polio

Flu

Anemia

Attention Deficit
Hyperactivity Disorder

Reflux or Ulcers

Seizures

Anxiety

Glaucoma

Liver Disease

Concussion

Arthritis

Lupus

Bone Disease

Eczema

Asthma

Meningitis

Leg/foot Ulcers

Epilepsy

Cataracts

Chronic Lyme Disease

Diverticulitis

Headaches/Migraine

Chronic
Bronchitis

Gout

Infection

Urinary Tract
Infection

Lung Disease

Thyroid
(underactive/overactive)

Cold

Kidney Stones

Menstrual Status (answer these questions only if you are a female)
32. At what age did you have your first menstrual period? ___________
33. What was the date of your last menstrual period?______________
34. Have you ever been amenorrheic (only 1-2 periods in a year)? ________ If yes, for how
long?________
35. If your last menstrual cycle was greater than 28 days ago and/or you have a history of
amenorrhea are you currently under the care of a health care provider? ___________
36. Do you use oral contraceptives or hormone replacement therapy? ________
Which kind? ____________________ What dose?______ If yes, for how long? ____________
Do you take the withdrawal/Placebo pills?___________
37. Do you use Depo-Provera for birth control? _________
If yes, for how long have you used this method?_________
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38. Have you ever experienced menstrual irregularity?_____ Please describe (i.e. number of
skipped menses, or prolonged menses): _____________________ How long did this
occur?__________
39. Do you currently experience a menstrual cycle? _______
If yes, how many periods in a year do you have? _______ and how many days between periods?
_______
If no, how many years ago did you have a regular menstrual cycle (10-12 a year)?_________
Answer question 40 if you are a male
40. Do you regularly use erectile dysfunction medication (i.e. Viagra, Levitra)?
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No

Yes

Appendix 3
Nitrate Food Frequency Questionnaire
Never
Item
Broccoli
Cauliflower
Spinach
Beets
Beetroot
juice
Radishes
Turnips
Carrots
Lettuce
Kale
Arugula
Cabbage
Fennel
Parsley
Leeks

Serving

once
per
week

2-4
per
week

5 florets
1/2 cup
1 cup
1 cup
1 cups
1 cup
1 cup
1
normal/
10 baby
1 cup
1 cup
1/2 cup
1 cup
1 bulb
1 cup
1 cup

Processed
meats (hot
1 link
dogs)
Cured meats
(sausage/cold 1 slice
cuts)
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5-6 per
week

Daily

Once
per
month

Once
per 3
months

Once
per
year
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the American College of Sports Medicine’s 61st Annual Meeting, Orlando, FL, May 27May 31, 2014.

•

Fitzgerald KL, Babcock WC, Hughes WE, Lefferts WK, Leyer BK, Redmond JG,
Heffernan KS. “Aortic Wave Reflections Are Associated With Anaerobic Power
Production In Young Adults.” Presented at the American College of Sports Medicine’s
61st Annual Meeting, Orlando, FL, May 27-May 31, 2014.

•

Heffernan KS, Spartano NL, Lefferts WK, Augustine JA, Hughes WE, Gump BB.
“Arterial Stiffness and Pressure from Wave Reflections during Cognitive Challenge in
Children and Adults.” Presented at the American College of Sports Medicine’s 61st
Annual Meeting, Orlando, FL, May 27-May 31, 2014.

•

Redmond JG, Babcock WC, Leyer BK, Fitzgerald KL, Lefferts WK, Hughes WE,
Heffernan KS. “Effect of Body Composition on Anaerobic Power in Division I Women's
Ice Hockey Players.” Presented at the American College of Sports Medicine’s 61st
Annual Meeting, Orlando, FL, May 27-May 31, 2014

•

Babcock WC, Leyer BK, Fitzgerald KL, Lefferts WK, Hughes WE, Redmond JG,
Heffernan KS. “No Sex Differences in Carotid Artery Stiffness and Blood Flow
Pulsatility Following High Intensity Exercise.” Presented at the American College of
Sports Medicine’s 61st Annual Meeting, Orlando, FL, May 27-May 31, 2014
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•

Martin ED, Augustine JA, Spartano NL, Lefferts WK, Heffernan KS. “No Association
Between Body Fat And Arterial Stiffness In Non-obese Women.” Presented at the
American College of Sports Medicine’s 61st Annual Meeting, Orlando, FL, May 27-May
31, 2014

•

Spartano NL, Augustine JA, Lefferts WK, Hughes WE, Morse BG, Martin ED, Gump
BB, Heffernan KS. “Physical Activity is Associated with Attenuated Carotid Blood
Pressure Response to Mental Stress.” Presented at the American College of Sports
Medicine’s 61st Annual Meeting, Orlando, FL, May 27-May 31, 2014

•

Hughes WE, Spartano NL, Lefferts WK, Augustine JA, Heffernan KS. “Sex Differences
in Arterial Stiffness and Left Ventricular Pressure Energetics.” Presented at the American
College of Sports Medicine’s 61st Annual Meeting, Orlando, FL, May 27-May 31, 2014

•

Augustine JA, Lefferts WK, Martin ED, Spartano NL, Heffernan KS. “Vascular
Function in Exercise-Trained Females.” Presented at the American College of Sports
Medicine’s 61st Annual Meeting, Orlando, FL, May 27-May 31, 2014

•

Heffernan K, Lefferts WK, Augustine J. “Resistance exercise-induced increases in
carotid artery stiffness do not affect cerebral blood flow pulsatility.” Presented at the
North American Artery Society 3rd Annual Meeting, Chicago, IL, September 6-7, 2013.

•

Heffernan KS, Lefferts WK, Tarzia BJ, Kasprowicz AG. “Arterial Stiffness And Shear
Rate Patterns In The Femoral Artery During Lower Limb Reductions In Transmural
Pressure.” Presented at the American College of Sports Medicine’s 60th Annual
Meeting, Indianapolis, ID, May 28-June 1, 2013.

•

Tarzia BJ, Kasprowicz AG, Lefferts WK, Heffernan KS. “Physical Activity, Sedentary
Behavior and Blood Pressure in Young Adults.” Presented at the American College of
Sports Medicine’s 60th Annual Meeting, Indianapolis, ID, May 28-June 1, 2013.

•

Lefferts WK, Hultquist E, Heffernan K, Fehling P, Smith D. “Vascular changes
following exercise-induced hyperthermia.” Presented at the American College of Sports
Medicine’s 60th Annual Meeting, Indianapolis, ID, May 28-June 1, 2013.

•

† Lefferts WK, Hultquist EM, Barr DA, Storer TW, Cooper CB, Fehling PC, Smith DL.
Cardiovascular and metabolic responses during Maximal Incremental Exercise in
Firefighter’s Personal Protective Equipment. Presented at the American College of
Sports Medicine’s 59th Annual Meeting, San Francisco, CA, May 29-June 2, 2012.

•

Smith DL, Barr DA, Hultquist EM, Lefferts WK, Haller JM, Fehling PC, Storer TW,
Cooper CB. Does Exercise Mode or Protocol Alter the Chronotropic Index? Presented at
the American College of Sports Medicine’s 59th Annual Meeting, San Francisco, CA,
May 29-June 2, 2012.

*Slide presentation; †Award recipient
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•

Haller JM, Hultquist EM, Lefferts WK, Smith DL, Fehling PC. “Influence of Clothing
Layers Under Firefighting Protective Clothing on Physiological/Perceptual Responses to
Intermittent Work.” Presented at the American College of Sports Medicine’s 59th Annual
Meeting, San Francisco, CA, May 29-June 2, 2012.

•

Hultquist EM, Arena L, Lefferts WK, Storer TW, Cooper CB, Fehling PC, Smith DL.
“The Effect of Pre-cooling on Cardiovascular and Metabolic Strain During Incremental
Exercise.” Presented at the American College of Sports Medicine’s 59th Annual Meeting,
San Francisco, CA, May 29-June 2, 2012.

•

Smith DL, Hultquist E, Arena L, Lefferts WK, Fehling PC “Effect of Heat Acclimation
on Cardiac and Vascular Function, Oxygen Consumption, and Body Fluids.” Presented at
the American College of Sports Medicine’s 58th Annual Meeting, Denver, CO, May 31June 4, 2011.

Regional Presentations
• *† Lefferts WK, Hughes WE, White CN, Brutsaert TD, Heffernan KS. “Effect of Nitrate
on Cognitive Function and Neurovascular Coupling at High Altitude” Presented at the
Mid-Atlantic Regional Conference American College of Sports Medicine, Harrisburgh,
PA, October 31-November 1, 2014.
•

Babcock MC, Lefferts WK, Heffernan KS. “Relation Between Exercise Central
Hemodynamic Load and Resting Cardiac Structure and Function in Young Men”
Presented at the Mid-Atlantic Regional Conference American College of Sports
Medicine, Harrisburgh, PA, October 31-November 1, 2014.

•

Augustine JA, Lefferts WK, Spartano NL, Hughes WE, Gump BB, Heffernan KS.
“Physical Function, Cognitive Function, and Aortic Stiffness in Older Adults” Presented
at the Mid-Atlantic Regional Conference American College of Sports Medicine,
Harrisburgh, PA, October 31-November 1, 2014.

•

Martin E, Augustine JA, Spartano NL, Lefferts WK, Heffernan KS. “No Association
between Body Fat and Arterial Stiffness in Non-obese Women” Presented at the MidAtlantic Regional Conference American College of Sports Medicine, Harrisburgh, PA,
November 1-2, 2013.

•

Augustine JA, Lefferts WK, Martin E, Spartano NL, Heffernan KS. “Vascular Function
in Exercise-Trained Women.” Presented at the Mid-Atlantic Regional Conference
American College of Sports Medicine, Harrisburgh, PA, November 1-2, 2013.

•

Spartano NL, Augustine JA, Lefferts WK, Hughes W, Morse B, Martin E, Bill K, Gump
B, Heffernan KS. “Carotid blood pressure reactivity is associated with carotid intimamedia thickness independent of central adiposity.” Presented at the Mid-Atlantic
Regional Conference American College of Sports Medicine, Harrisburgh, PA, November
1-2, 2013.

*Slide presentation; †Award recipient
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•

Hughes WE, Spartano NL, Lefferts WK, Augustine JA, Heffernan KS. “Sex differences
in arterial stiffness and left ventricular pressure energetics.” Presented at the MidAtlantic Regional Conference American College of Sports Medicine, Harrisburgh, PA,
November 1-2, 2013.

•

*Lefferts WK, Augustine J, Heffernan K. “Resistance exercise, carotid artery stiffness,
and cerebral blood flow pulsatility” Presented at the Mid-Atlantic Regional Conference
American College of Sports Medicine, Harrisburgh, PA, November 1-2, 2013.

•

*Lefferts WK, Hultquist E, Heffernan K, Fehling P, Smith D. “Vascular changes
following exercise-induced hyperthermia.” Presented at the Mid-Atlantic Regional
Conference American College of Sports Medicine, Harrisburgh, PA, November 2-3,
2012.

•

Tarzia BJ, Kasprowicz AG, Lefferts WK, Heffernan KS. “Physical Activity, Sedentary
Behavior and Blood Pressure in Young Adults.” Presented at the Mid-Atlantic Regional
Conference American College of Sports Medicine, Harrisburgh, PA, November 2-3,
2012.

•

*† Lefferts WK, Hultquist E, Arena L, DeBlois J, Fehling PC, Smith DL. “Effect of
Base Layers on Physiological and Perceptual Strain during Exercise in Personal
Protective Equipment.” Presented at the Mid-Atlantic Regional Conference American
College of Sports Medicine, Harrisburgh, PA, November 5-6, 2010.

•

Hultquist E, Arena L, DeBlois J, Lefferts WK, Fehling PC, Smith DL. “Effect of Heat
Acclimation on Cardiac and Vascular Function, Oxygen Consumption, and Body Fluids.”
Presented at the Mid-Atlantic Regional Conference American College of Sports
Medicine, Harrisburgh, PA, November 5-6, 2010.

Grants/Support
1. American College of Sports Medicine Foundation Research Grant ($4,983.93) – PI
The effect of Dietary Nitrate on Cognitive and Cerebrovascular Function in Hypoxia (2014)
2. Syracuse University School of Education Travel Grant ($400) – PI (2014)
3. Syracuse University Graduate School Organization Travel Grant ($200) – PI (2014)
Professional Organizations
American College of Sports Medicine (ACSM), 2010 – present.
Mid-Atlantic American College of Sports Medicine (MARC), 2010 – present.
Community Service Activities
Invited Talks
• Lefferts WK, Spartano N, Augustine J. "Cardiovascular function and health
implications: research and application." Presented to the Syracuse University School of
Education Board of Visitors, Syracuse, NY, September 21, 2013.
*Slide presentation; †Award recipient
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•

Lefferts WK “Summer Collaborative Research Experience.” Presented at the Skidmore
College Board of Trustees Reception and Dinner, Saratoga Springs, NY, February 24,
2011.

Invited Presentations
• Lefferts WK, Hultquist E, Arena L, Fehling, PC, Smith, DL. Effects of Altered Core
Temperature on Cardiovascular Strain, Thermal Strain and Performance. Presented at
Undergraduate Research Conference, Saratoga Springs, NY, October 1, 2011.
•

Lefferts WK, Hultquist E, Arena L, Fehling PC, Smith, DL. Effects of Altered Core
Temperature on Cardiovascular Strain, Thermal Strain and Performance. Presented at
Skidmore College Academic Festival, Saratoga Springs, NY, May 4, 2011.

•

Lefferts WK, Hultquist E, Arena L, DeBlois J, Fehling PC, Smith DL. Effect of Base
Layers on Physiological and Perceptual Strain during Exercise in Personal Protective
Equipment. Presented at Skidmore College Celebration Weekend Spotlight on
Collaborative Research, Saratoga Springs, NY, October 15, 2010.

•

Lefferts WK, Hultquist E, Arena L, DeBlois J, Fehling PC, Smith DL. Effect of Base
Layers on Physiological and Perceptual Strain during Exercise in Personal Protective
Equipment. Presented at Final Summer Collaborative Research Meeting, Saratoga
Springs, NY, August 6, 2010.

Invited Lectures
• Lefferts WK, Cardiovascular Physiology: Form and Function. Presented to PPE 497:
Exercise Physiology, Syracuse University, Syracuse, NY, October 28, 30, 2014.
•

Lefferts WK, Novel Measures of Body Composition. Presented to PPE 500: Body
Composition, Syracuse University, Syracuse, NY, April 22, 2014.

•

Lefferts WK, Cardiovascular Responses to Exercise. Presented to PPE 497: Exercise
Physiology, Syracuse University, Syracuse, NY, February 11, 2013.

Certification/Honors/Awards
• MS Research Award, Mid-Atlantic Regional Chapter, ACSM, 2014
• American College of Sports Medicine (ACSM) Environmental and Occupational
Physiology Interest Group MSc/BSc Research Award, 2012
• Graduated Magna Cum Laude, Skidmore College, Health and Exercise Sciences, 2011
• Margaret Paulding Award in Exercise Science, Skidmore College, 2011
• Matthew Kerner Undergraduate Research Award, Mid-Atlantic Regional Chapter,
ACSM, 2010
• American Red Cross CPR
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